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ABSTRACT 
 
Ticks seriously affect mammals and immunization of host is considered as 
sustainable option for their management. Identification and validation of protective 
molecules are major challenges in developing vaccines against ticks. Based on 
understanding tick saliva-host interaction, efforts have been dedicated to tick control to 
diminish their deleterious effects. By utilization of tick saliva proteins previously 
identified by cDNA phage display library, transcriptomic and immune-proteomic 
studies, current study focuses on investigation of roles of 15 selected Amblyomma 
americanum and Ixodes scapularis recombinant tick saliva proteins (rTSPs) on host 
macrophage function. The effect of rTSPs on macrophage secretion of pro- and anti-
inflammatory cytokines (TNF-, IL-1, IL-6, IL-10, TGF-β) was investigated. Moreover, 
the functional role was examined by in vivo paw edema assay, cytokine and chemokine 
analysis. In vitro and in vivo investigations show that five Amblyomma americanum 
rTSPs, AamIGFBP (Insulin like growth factor binding proteins) rP-1, AamIGFBP-rP6 
Short (S) and AamIGFBP-rP6 Long (L), Serine protease inhibitor (serpin) 8 (AAS8) and 
AamTCI (tick carboxypeptidase inhibitor), out of 15 are pro-inflammatory (PI) rTSPs as 
revealed by expression of pro-inflammatory costimulatory markers, cytokines, 
chemokines and signaling molecules. Interestingly, the two rTSPs serpins, AAS27 and 
AAS41, are anti-inflammatory (AI) rTSPs and appear to reverse the expression of co-
stimulatory markers and cytokines induced by LPS and PI-rTSPs. Results indicate that 
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PI- and AI-rTSPs function in host evasion and thus may serve as potential candidate for 
anti-tick vaccination.  
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NOMENCLATURE 
 
DNA Deoxyribonucleic Acid 
RNA Ribonucleic Acid 
CDC Centers for Disease Control  
h Hour 
IL Interleukin 
Th T-helper cells 
SERPIN Serine Protease Inhibitor 
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CD Cluster of differentiation 
TGF Transforming growth factor 
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CHAPTER I 
INTRODUCTION 
General Biology  
Ticks are obligatory blood feeding ectoparasites that are distributed in nearly all 
habitable land (Sonenshine 1991). Ticks are classified in the order Ixodida, which 
contains three families: Argasidae, Ixodidae, and Nuttalleillidae. The family 
nuttalliellidae contains, which contains one species, Nuttalliella namqua is the least 
studied, and has only been reported in southern African countries of Tanzania, Namibia 
and South Africa (Keirans et al., 1976; Guglielmone et al, 2010; Mans et al., 2011). The 
other two tick families; argasidae and ixodidae are extensively studied, and have a global 
presence. The family argasidae, commonly known as “soft ticks” is subdivided into five 
genera containing at least 170 species. The family ixodidae commonly referred to as 
hard ticks is subdivided into five subfamilies that are organized into 12 genera and more 
than 650 species (Sonenshine 1991; Moon et al., 2002). Hard and soft ticks are so called, 
because of the texture of cuticle, which is hard and sclerotized for the former, and soft 
and leathery for the latter (Sonenshine 1991).  
The tick life cycle has four stages: egglarvanymphadult. Larva and 
nymph are commonly referred to as immature as they are not sexually developed. Except 
in the egg stage, each of the other tick life stages require a blood meal to develop to the 
next stage. For larvae and nymphs, they require a blood meal to molt to the next stage, 
while adult females take a blood meal to lay eggs and then die. Ticks infest a broad 
range of vertebrates, mammals, birds, reptiles and amphibians. Hard ticks are further 
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classified as one-, two-, or three- host ticks. One-host ticks spend their entire life cycle 
on the same host. For two-host ticks, both immature stages feed on the same host, while 
the adult tick feeds on a separate host. For three-host ticks, each tick feeding stage feeds 
on separate host. In addition to physical differences, hard and soft ticks are further 
distinguishable in how they feed. Whereas soft ticks take multiple blood meals for short 
periods of up to 5 min, hard ticks take a single blood meal that is completed over an 
extended period of 4-7 days for immature ticks (larvae and nymphs) and about 10-14 
days for adult ticks (Sonenshine 1991).  
Medical and Veterinary Importance   
Medical and veterinary effects of ticks are described as direct or indirect, with 
the former mostly documented for hard ticks. Documented direct effects include 
paralysis and toxicosis, anemia, exsanguination in heavy tick infestations, stress, 
damaged skin impacting economic value of hides, and wounds at feeding site 
predisposing animals to secondary infections (Klompen et. al., 1996; Estrada-Peña and 
Jongejan, 1999; Jongejan and Uilenberg, 2004). Recent reports have documented 
devastating direct effects of tick infestations on wildlife (Fyumagwa et al., 2007; 
Keesing et al., 2013; Dantas-Torres 2015).  
Although direct effects can lead to high economic loss, ticks are primarily known 
for their indirect effects or vector functions. Ticks can transmit multiple disease-causing 
pathogens including bacteria, protozoa, and viruses (Brites-Neta et al., 2015). Ticks 
outpace any other known arthropod vectors in terms of the diversity of transmitted 
disease agents, and they are considered second to mosquitoes in terms of the public 
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health impact of tick borne disease (TBD) agents. Medical and veterinary impacts of 
ticks and TBDs are well documented. In the livestock industry nearly 80% of the world’s 
cattle are affected by TBD agents. Collectively losses due to direct effects of ticks and 
TBD infections amount to millions of US dollars annually (Jongejan and Uilenberg, 
2004). Table 1 summarizes ticks and tick borne diseases of veterinary importance. 
 
 
 
Table 1 List of tick borne diseases of veterinary importance  
 
Tick vector Pathogen Disease Livestock/Domestic 
Animal 
Endemic 
Countries 
Rhiphicephalus microplus;  
Ixodes ricinus; 
Haemaphysalis spp.; 
Dermacentor spp.; 
Hyalomma spp.; R. 
sanguineus 
Babesia 
bigemina; B. 
bovis; B. 
divergens; 
B. motasi; B. 
equi; B. 
caballi; 
Babesia 
gibsoni 
Babesiosis/Tick 
fever, Equine 
piroplasmosis 
Cattle, Goats, 
Sheeps, Horses, 
Dogs 
Central and 
South America, 
Europe, Africa, 
Australia and 
Asia 
 
 
Argas persicus.; 
Ornithodoros spp.; 
Dermacentor spp..; Ixodes 
spp.; Hyalomma spp.; 
Rhiphicephalus spp. 
 
Anaplasma 
spp. 
Bovine, 
Equine, Canine 
Anaplasmosis 
Cattle, Horses, Dogs India, US, 
Africa, South 
America 
Amblyomma spp. 
R. sanguineus 
Ehrlichia                                   
ruminantium 
Cowdriosis or 
Heartwater 
Cattle, Goats, 
Sheeps 
Southern, 
eastern and 
western African 
countries and in 
Madagascar 
 
E. canis; E. 
chaffeensis; E. 
ewingii 
Ehrlichiosis Dogs India, US, 
Africa, South 
America, North 
America 
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Table 1 Continued  
 
Tick vector Pathogen Disease Livestock/Domestic 
Animal 
Endemic 
countries 
Ornithodorus moubata African swine 
fever virus 
African swine 
fever virus 
disease 
Swine Africa, Europe, 
Carribean  
R. appendiculatus; 
H. anatolicum; 
Haemaphysalis spp.; A. 
variegatum 
 
Theilaria spp. 
 
East coast fever 
Tropical 
Theileriosis 
Cattle, Sheep, goat Eastern and 
southern Africa, 
Northern Africa, 
southern Europe, 
the Near East and 
the Far East, India 
D. andersoni; D. 
variabilis; 
H. truncatum; 
I. holocylus; 
Rhiphicephalus spp. 
 
 Paralysis 
Sweating 
sickness, 
Australian tick 
paralysis, tick 
toxicosis 
Cattle, Dogs, Cats Australia, USA, 
Africa, South 
America, India 
R. sanguineus Bartonella Bartonellosis, 
Cat scratch 
disease 
Cats, Dogs Europe, North 
America, Africa 
and China 
Ixodes ricinus Louping ill 
virus 
Louping ill  Sheep/Grouse British Isles 
R. appendiculatus Nairobi sheep 
disease virus 
Nairobi sheep 
disease  
Sheep Africa 
Hyalomma spp. Crimean-Congo 
hemorrhagic 
fever virus 
Crimean-
Congo 
hemorrhagic 
fever 
Cattle Africa, Middle 
east and Asia 
Dermacentor spp.; A. 
americanum 
Cytauxzoon felis Cytauxzoonosis Cat North America 
 
 
 
Some of the most economically important TBD agents of livestock include the 
globally distributed Rhipicephalus (formerly Boophilus) microplus and R. annulatus 
transmitted bovine babesia parasites: Babesia bovis and B. bigemina, R. appendiculatus 
vectored Theileria parva parva in east and southern Africa, Amblyomma variegatum 
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transmitted Ehrlichia ruminantium in Africa, and Anaplasma marginale transmitted by 
multiple tick species including Dermancentor spp and R. microplus worldwide (Jongejan 
and Uilenberg, 2004; Marcelino et. al., 2012). Other important TBDs include equine 
piroplasmosis caused by B. caballi and T. equi that are vectored by Dermacentor spp 
ticks as well as A. mixtum (formerly A. cajennense) (Holbrook et al., 1968, Kerber et al., 
2009). In companion animal health, important TBDs such as canine ehrlichiosis (Ewing 
et al., 1997), anaplasmosis, babesiosis (Kjemtrup and Conrad 2006), bartonnellosis 
(Breitschwerdt et al., 2010), and hepatozoonosis (Ewing and Panciera 2003), Lyme 
disease (Littman et al., 2006), Rocky Mountain Spotted Fever (Greene et al., 1985), 
Cytauxzoonosis   (Reichard et al., 2009) have been documented.  
Since the description of Borrelia burgdorferi as the causative agent for human 
Lyme disease in the 1980’s there was a renewed focus on the impact of ticks in public 
health (Burgdorfer et. al., 1982; Johnson et. al., 1984). For instance, 15 previously 
unknown human TBD agents were reported between 1982 and 2001 (Parola and Raoult, 
2001). At the time of drafting this dissertation, the US Centers for Disease Control 
(CDC) listed 16 reportable human TBD agents (https://www.cdc.gov/ticks/diseases) 
(Table 2).  Moreover, the CDC, listed four other important human TBD agents 
including, the Crimean-Congo hemorrhagic fever, Kyasanur forest disease, Omsk 
Hemorrhagic fever and tick borne encaphalitis 
(https://www.cdc.gov/ticks/diseases/abroad.html).  It is also interesting to note that, of 
the 24 vector borne disease agents that are listed by the United Nation’s World Health 
Organization, seven (Crimean-Congo Hemorrhagic fever, Lyme disease, relapsing fever 
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borreliosisis, spotted fever and Q fever rickettsial disease, Tick-borne encephalitis, and 
tularemia) are tick borne (http://www.who.int/mediacentre/factsheets/fs387/en/). 
 
 
 
Table 2 Tick borne diseases of the United States documented in humans (CDC, USA) 
 
Tick species Causative agent Disease 
Ixodes scapularis 
Ixodes ricinus 
Anaplasma marginale Anaplasmosis 
Ixodes scapularis Babesia microti Babesiosis 
Ixodes scapularis Borrelia mayonni Lyme disease 
Ixodes scapularis Borrelia miyamotoi Lyme disease 
Unknown Bourbon virus Bourbon disease 
Dermacentor andersoni Coltivirus Colorado tick fever 
Amblyomma americanum Ehrlichia spp. Ehrlichiosis 
Amblyomma americanum Heartland virus Heartland virus disease 
Ixodes scapularis 
Ixodes pacificus 
Borrelia burgdorferi Lyme disease 
Ixodes scapularis 
Ixodes cookei 
Powassan virus Powassan disease 
Amblyomma maculatum Rickettsia parkeri Rickettsiosis 
Dermancentor variabilis 
Dermacentor andersoni 
Rhiphicephalus sanguinineus 
Rickettsia rickettsii Rocky mountain spotted fever 
Amblyomma americanum Unknown STARI (Southern tick-associated 
rash illness) 
Ornithodorus spp. Borellia hermsii 
Borellia parkeri 
Tick borne relapsing fever 
Dermacentor occindentalis Rickettsia phillipi 364D rickettsiosis 
Dermacentor variabilis 
Dermacentor andersoni 
Amblyomma americanum 
Francisella tularensis Tularemia 
  
 
 
Prevention of tick borne diseases 
There had been attempts to develop effective vaccines against major TBD agents 
particularly for use in animals including vaccines against cattle T. parva parva (Radley 
et al., 1975), bovine babesiosis and anaplasmosis (Montenegro et al., 1992; Harper et al., 
1994, Callow et al., 1997; Vercruysse et al., 2004). In public health, a vaccine against 
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the Lyme disease agent (Steere et al., 1998), which was commercialized over a brief 
period was withdrawn as model animal protective levels were not collaborated in 
vaccinated individuals (Rose et al., 2001; Lathrop et al., 2002). Thus, in the absence of 
effective vaccines against major TBD agents, prevention of animal and human TBD has 
depended on killing ticks. Although other approaches such as environmental 
management (Pavela et al., 2016) and biological methods (Kirkland et al., 2004a; 
Kirkland et al., 2004b; Hartelt et al., 2008) of ticks has been attempted to control tick 
infestations, killing ticks using acaricides has been the most reliable (Awumbila 1996; 
Holdsworth 2005). Despite the usage of these acaricides being effective in short term, 
they do not offer a permanent solution due to variety of serious limitations that include 
ticks developing resistance against multiple chemical acairicides and environmental 
contamination (Abbas et al., 2014; Brito et al., 2011; Guerrero et al., 2012; Rosario-Cruz 
et al., 2009). Tick development of resistance against tick infestation is particularly 
serious as costs for development of novel acaricide chemistry were estimated at over 
$100 million (Graf et al., 2004; de la Fuente et al., 2007). If acaricide based tick control 
methods were to fail, there would be catastrophic losses in the livestock industry and an 
unprecedented number of human TBD cases. Due to serious limitations of acaricide 
based tick control, alternative tick control methods have been documented (Mulenga et 
al., 1999; 2001; Willadsen et al., 1988; 1995; 2004; de la Fuente and Merino 2013). 
Immunization of animals against tick feeding has been validated as an effective and 
sustainable alternative tick control method (Rodríguez et. al. 1995; Willadsen et. al., 
1995; Kumar et. al., 2009; Canales et. al., 2009; Merino et. al., 2011; Mulenga et. al., 
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1999; Galaï et. al., 2012; Saimo et. al., 2011; Sugino et. al., 2003; Prevot et. al., 2007).  
Immunization of animals against tick feeding: The need for effective anti-tick 
vaccine antigens  
The concept of immunizing animals against tick feeding was based on 
observations that repeated infestation of rabbits by Dermacentor variabilis larvae 
provoked strong immunity that significantly reduced feeding performance of subsequent 
tick infestations (Trager et al., 1939).  This work suggested that  molecules existed in the 
tick that could be targeted for anti-tick immunization. These observations were 
reproduced by several other investigators (Kumar et al., 2009, Rechav and Dauth 1987, 
Schwartz et al., 1990, Shapiro et al., 1986) further confirming that tick molecules could 
be targeted for anti-tick vaccine development. Work by Australian scientists leading to 
the first commercialization of an anti-tick vaccine against R. microplus (Willadsen et al., 
1995), TickGARD® Plus, provided credence to the concept of anti-tick immunization. 
Furthermore, scientists in Cuba validated the effectiveness of anti-tick immunization 
when they commercialized Gavac Plus®, a TickGARD sister vaccine as both vaccines 
were essentially based on the same antigen target molecule, Bm86 (De la Fuente et al., 
1999, Valle et al., 2004). The limitations of both TICKGARD plus and GAVAC plus 
were quickly realized (De la Fuente, 2007): being effective against a single species and 
apparently tick strain specific as the vaccine appeared was not effective across 
geographic regions (De la Fuente, 2000). Additionally, immunizations with Bm86 
homologs in other tick species did not confer protective anti-tick immunity (De Vos et 
al., 2001). Thus, the search for effective target anti-tick vaccine antigens in other tick 
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species was justified. The availability of effective anti-tick vaccine antigens is 
recognized as the limiting factor toward development and adoption of anti-tick 
immunization as the global strategy for anti-tick immunization (De la Fuente, 2007; 
Mulenga et al., 2001; Radulovic et al., 2015; Lewis et al., 2015; Kim et al., 2016; Tirloni 
et al., 2014; 2016). Without successful feeding, ticks can neither cause damage to its 
host nor transmit TBD agents. Thus, there has been a renewed focus to understand the 
molecular basis of tick feeding physiology as a means through which effective target 
anti-tick vaccine antigens can be discovered (Oliveira et al., 2013; Tirloni et al., 2014; 
Shwarz et al., 2014; Villar et al., 2014; Lewis et al., 2015; Kim et al., 2016).  
Understanding the molecular basis of tick feeding physiology as a means of 
identifying effective anti-tick vaccine antigens. 
Ticks accomplish blood meal feeding via pool feeding. Ticks feed by disrupting 
host tissue and sucking blood that collects into the wounded area, also referred to as the 
"tick-feeding lesion" (Sonenshine, 1991). This feeding style triggers host tissue repair 
and immune reactions that include inflammation, blood clotting, and complement 
activation systems that are aimed at stopping further blood loss and initiating tissue 
repair. Ticks overcomes host defenses, successfully feed, and transmit TBD agents by 
secreting diverse pharmacologically active agents in their saliva to suppress host 
defenses (Ribeiro 1989). Several lines of evidence have shown that tick salivary 
secretions include molecules that promote tick feeding and transmission of TBD agents. 
There have been considerable research interests in discovery of tick molecules that 
regulate tick feeding as these represent potential targets for anti-tick vaccine 
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development. Table 3 provides a summary of studies in ticks and host interactions over 
10 years prior to start of my dissertation in 2013, while Table 4 summarizes studies 
during the five years of my PhD dissertation research. Collectively these studies 
demonstrate that the majority of our knowledge on tick and host interactions utilized 
crude tick protein extracts with a limited number of studies utilizing recombinant tick 
proteins. Toward identification of proteins that ticks inject into the host during feeding, 
there has been a concerted effort to determine molecular identities of tick proteins. Some 
of the described tick feeding promoting activities in tick saliva have included 
vasodilators that are thought to increase blood flow to the feeding site (Ribeiro et al., 
1992), anti-haemostatics to prevent blood clotting (Ribeiro et al., 1985; Mulenga et 
al.,2013; Ibelli et al., 2014; Kim et al., 2015), anti-complement factors (Franco et al., 
2016, Hourcade et al., 2016, Barratt et al., 2011), immune-suppressants (Juncadella et 
al., 2007), and inhibitors/modulators of innate and adaptive immunity (Cavassani et al., 
2005, Vachiery et al., 2015; Scholl et al., 2016). This has been aided by recent 
publication of the I. scapularis (Hill and Wikel, 2005; Gulia-Nuss et al., 2016) and R. 
microplus (Geurrero et al., 2006) genomes. In other studies, tick salivary gland 
transcriptomes (Aljamali et al., 2009; Karim et al., 2011; Ribeiro et al., 2017; Moreira et 
al., 2017), immuno-proteomes/transcriptomes (Lewis et al., 2015), and tick saliva 
proteomes (Oliveira et al., 2013; Tirloni et al., 2014; 2015; Shwarz et al., 2014, Villar et 
al., 2014, Kim et al., 2016; Mudenda et al., 2014) were published. These studies have 
contributed to our understanding on molecular identification of proteins that the tick may 
inject into the host to regulate tick feeding and facilitate transmission of TBD agents.  
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The next phase of tick feeding physiology research and the focus of this 
dissertation is in part to understand the functional roles of proteins that the tick injects 
into the host in tick feeding regulation. This knowledge will likely reveal proteins that 
can be targeted for development of novel methods to prevent transmission of TBD 
agents. In this dissertation research, cell culture and in vivo approaches were utilized to 
define the role(s) of 15 recombinant tick saliva proteins in tick feeding regulation as 
revealed by effects on macrophage function. This dissertation has contributed to our 
understanding of how ticks evade the host’s defense mechanisms.
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Table 3 List of studies based on immuno-modulatory effects of tick saliva (Year 2003-13)  
Tick species Tick molecule Host reaction Host molecule References 
Rhiphicephalus 
sanguineus 
Saliva (engorged) Resistant animal: Induce basophils and 
neutrophils infiltration 
Susceptible animal: Effect delayed type 
hypersensitivity (DTH), basophils and 
mononuclear cell infiltration, protective 
immunity 
Basophil and neutrophil 
infiltration/ DTH 
Ferreira et al., 2003  
 
Hyalomma 
anatolicum 
Feeding (F) Affect T cell proliferation Increased CD4+/CD8+ T cells 
ratio, increase in circulating B 
cell count 
Boppana et al., 2004 
Ixodes ricinus Saliva (Partially fed)
  
Inhibit B cell proliferation (LPS/ Borrelia 
OSP C induced)  
B cells Hannier et al., 2004 
 
Rhiphicephalus 
sanguineus
  
Saliva (engorged) Inhibition of bone marrow derived 
differentiation, maturation and function 
induced by LPS   
Suppress cell surface marker 
expression of B cell: CD40, 
CD80 and CD86, CD54  
Cavassani et al., 2005  
 
I. ricinus 
  
Salivary gland (SG) 
(partially engorged) 
Suppress Cytokine production in 
susceptible mice  
Epidermal cells: Downregulate 
TNFα and increase Th2 
cytokine IL4 in C3H mice 
Pechova et al., 2004 
 
Dermacentor 
reticulatus 
Amblyomma 
variegatum 
I. ricinus
  
SG Anti-cytokine activity IL-8, MCP-1, MIP-1α, 
RANTES, eotaxin, IL-2 and IL-
4 
Hajnicka et al., 2005 
 
D. andersoni
  
Saliva (4-5 days 
infestation) 
Induce extramedullary erythropoiesis Spleen: High CD49, low 
CD11a 
Dash et al., 2005 
 
D. andersoni 
I. scapularis 
SG (Partially fed) Reduce adhesion molecule expression 
ICAM and VCAM 
Endothelial cells : D. andersoni 
: downregulate ICAM-1; 
I. scapularis: Downregulate P-
selectin and VCAM-1 
Maxwell et al., 2005 
 
I. ricinus
  
Saliva, SG (Partially 
fed) 
Anti-inflammatory activity  TNFα inhibitory activity  Konik et al., 2006 
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Table 3 Continued 
 
Tick species Tick molecule Host reaction Host molecule References 
I. ricinus Saliva (Partially 
engorged) 
Th2 immune response CD4+ T cells: Increase in IL-4 
cytokine leads Th2 immunity 
Mejri and Brossard 2007  
 
A. variegatum SG, Females: 2&8 
days, Males: 3, 7 and 
11 days  
Altered chemokine and cytokine activity Anti- chemokine CXCL8, 
MCP-1,MIP-1, CCL3, CCL11
  
Vancova et al., 2007 
 
R. sanguineus SG: Evasin 1 Neutralize chemokine activity CCL3, CCL4 Fraenschuh et al., 2007  
I. scapularis SG, Prostaglandin E2 Effect dendritic cell (DC) function CD40, CD86, MHC II, CD4+T 
cell proliferation, IL-2 
Sa-Nunes et al., 2007  
R. sanguineus Saliva (fully 
engorged)  
Dendritic cell migration Macrophage inflammatory 
protein α (MIPβ), T cell, CCR5 
Oliviera et al., 2008  
I. ricinus Salp15 Borrelia burgdorferi induced Pro-
inflammatory activity of Dendritic cells 
Effect molecule: DC-SIGN, 
decrease IL-6, TNFα on 
Dendritic cells 
Hovious et al., 2008 
 
I. ricinus SG (Partially 
engorged) 
DC migration, maturation and function Suppress B7-2 molecules, 
Induce Th2 response cytokines: 
IL-2, IL-4, IL-17 
Skallova et al., 2008  
R. sanguineus Evasin 1, 3, 4  Chemokine inhibitory properties Evasin 1: Suppress CCL3, 
CCL4, and CCL18; Evasin 3: 
suppress CXCL8 and CXCL1 
Deruaz et al., 2008 
 
A. cajannense Saliva Inhibition of Lymphocyte proliferation Induce Th2 response Castagnolli et al., 2008  
I. scapularis Saliva Th1 inhibiton Langerhan cells Vesely et al., 2009 
I. scapularis Sphingomyelinase 
like enzyme 
Th2 response Cytokine Il-4 expression Alarcon-Chaidez et al., 
2009 
R. sanguineus Saliva Inhibits maturation of DC Inhibit ERK and MAP kinase 
signaling molecules, induce  
IL-10 
Oliveira et al., 2010 
R. microplus Saliva, dopamine 
induced; F 
Adhesion of PBMCs and endothelial cell 
migration 
Resistant animal: high E 
selectin, Susceptible animal: 
high ICAM, VCAM, P selectin  
Carvalho et al., 2010 
I. ricinus Saliva Inhibition of proliferation and cytokine 
production 
Decrease in virus induced 
TNFα and IL-6 
Fialova et al., 2010 
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Table 3 Continued 
 
Tick species Tick molecule Host reaction Host molecule References 
A. variegatum, R. 
appendiculatus, 
D. reticulatus 
SG (various days of 
feeding) 
Affect Neutrophil chemoattractant 
property 
CXCL8, CXCL1 Vancova et al., 2010 
R. microplus SG  Th1 > Th2 polarization Macrophages: Increase in 
CD86 expression 
Brake et al., 2010 
D. variabilis Saliva (Partially 
engorged) 
Suppresses phagocytosis of macrophages; 
Th2 response 
Macrophages : Induce IL-4 and 
IL-10 cytokine response 
Kramer et al., 2011  
R. sanguineus Saliva (Engorged) DC differentiation, cytokine production 
and costimulatory molecule expression 
Inhibition IL-12p40, TNFα, 
increase IL-10 
Oliviera et al., 2011  
I. ricinus Saliva (Partially 
engorged) 
Decrease number of phagocytosing DCs Inhibition of TNFα, IL-6 and 
increase in IL-10, Borrelia 
exposed DC suppress 
proliferation of DC and Il-2 
production. 
Slamova et al., 2011 
 
I. ricinus Salp15 Inhibit Keratinocyte inflammation  Chemokine IL-8, MIP and 
antimicrobial peptide 
downregulation 
Marchal et al., 2011  
I. ricinus Ixodes ricinus 2 
(IRS-2) 
Inhibit paw edema formation Cathepsin G and Chymase Chmelar et al., 2011 
I. ricinus Saliva IFN signalling in DC STAT-1, Interferon β pathway Lieskovska and Kopecky 
2012 
I. scapularis Sialostatin L, 
cysteine protease 
inhibitor 
Inhibits Th9 derived IL-9 production IL-9 inhibition Horka et al., 2012  
R. microplus SG, (Partially fed) Macrophage responses Inhibition of LPS induced 
macrophage response: Suppress 
CD80, CD86, CD40, IL-12, 
TNFα expression 
Brake and Perez 2012 
 
I. ricinus Saliva (Partially 
engorged) 
DC response signalling pathways Suppression of Erk1/2, NFΚB 
and Akt signalling molecules 
Lieskovska and Kopecky 
2012 
I. scapularis Saliva (Partially fed) Suppress inflammatory response by 
macrophages 
Decreasing levels of IL8, 
TNFα, IL12, IL6 
Chen et al., 2012 
 
I. scapularis Saliva: 3, 6 and 12 h  Neutrophil driven response at bite site  Inflammatory genes Heinze et al., 2012 
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Table 4 List of studies based on immuno-modulatory effects of tick saliva (Year 2013-17) 
Tick species Tick 
molecule 
Host reaction Host molecule References 
A. americanum Serine 
protease 
inhibitor 6 
(AamS6) 
Anti-haemostatic functions Serine and papain like cysteine proteases Mulenga et al., 
2013 
R.appendiculat
us 
Japanin DC response Alter co-stimulatory molecules, co-inhibitory 
transmembrane molecules, pro-inflammatory/ anti 
inflammatory cytokine 
Preston et al., 
2013  
D. variabilis Saliva 
(partially 
fed), 
Prostaglandin 
E(2) 
Macrophage migration and cytokine 
expression 
Decrease pro-inflammatory cytokine; recruit fibroblast  Poole et al., 
2013 
I. scapularis Serine 
protease 
inhibitor 
IxscS-1E1 
Anti-haemostatic and anti-
inflammatory  
Cathepsin G, thrombin and trypsin Ibelli et al., 2014 
A. americanum Calreticulin No affect on plasma clotting and 
platelet aggregation 
Bind complement molecule C1q Kim et al., 
2015a 
A. americanum Serine 
protease 
inhibitor 19 
Anti-coagulant activity Inhibit trypsin, plasmin, factor Xa and factor XIa Kim et al., 
2015b 
I. scapularis Sialostatin 
L2 
IFN response in dendritic cells IFNβ stimulated genes: Interferon regulatory factor 7 
and IP-10 suppression 
Lieskovska et 
al., 2015 
I. ricinus Saliva, 
(partially 
engorged) 
Effect production of chemokine and 
cytokine response in mouse 
spenocytes 
Upregulate monocyte chemoattractant protein (MCP-1), 
thymus derived chemotactic agent 3 (TCA-3) and 
macrophage inflammatory protein (MIP-2) 
Langhansova et 
al., 2015) 
A. americanum Saliva, 
(Engorged 
tick) 
Dendritic cell differentiation Inhibit CD40, CD80, CD86, MHCII, CCR5, CCR7,IL-
12, IL-6 and TNFα, increase PD-L1 
Carvalho-Costa 
et al., 2015 
I. scapularis Sialostatin L 
and 
SialostatinL2  
Dendritic cell response to Borrelia 
spirochetes 
MIP-1α suppression, signalling molecules NfKb 
P13/Akr pathway suppression by SialoL2 
Lieskovska et 
al., 2015 
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Table 4 Continued 
 
Tick species Tick 
molecule 
Host reaction Host molecule References 
A. maculatum Infected 
Saliva with 
Rickettsia 
parkeri 
Inflammation, T cell response Lower inflammatory leukocytes, elevated C reactive 
protein, Th1 and pro-inflammatory cytokine in tick only 
animal 
Banajee et al., 
2015 
A. variegatum Saliva 
(partially 
fed) 
Impaired monosyte recruitment, 
poor mobilization of monocyte 
derived cells from skin to lymph 
nodes 
Dendritic cells: CD11c Vachiery et al., 
2015 
I. scapularis Saliva Monocytic transcript level, pro-
inflammatory mediators 
Increased IL10, decrease in IL-8, IL-6 and TNFα, TLR2 
expression 
Scholl et al., 
2016 
A. maculatum Saliva Downregulation of acute cellular 
and cytokine immune response 
Cutaneous cellular infiltration inhibition during acute 
Ricketsial infection 
Banajee et al., 
2016 
A. americanum AAS19 Binding with Heparin/heparin 
sulfate increase inhibitory activity of 
serine proteases of host; 
anticoagulant activity 
Thrombin, factor Xa and factor XIIa Radulovic et al., 
2017 
I. ricinus Saliva Effect chemokine, cytokine and 
leucocyte markers in skin 
Early tick bite skin: CCL2, CCL3, CCL4 predominance 
and CXCL1 and CXCL8, IL-1 and IL-5. Lymphocytes 
and lymphocyte chemoattractant pro-inflammatory 
cytokines did not differ 
Later tick bite skin: immune cells and mediator declined 
and lymphocytes increased. 
Glatz et al., 2017 
I. ricinus SG Primary mast cells Mast cell activation inhibition Bernard et al., 
2017 
Ornithodorus 
moubata 
Cystatin Dendritic cell maturation Target cathepsin S and C associated with maturation of 
dendritic cells 
Zavasnik et al., 
2017 
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Research significance 
 As summarized in Table 1, A. americanum and I. scapularis transmit a combined 
11 of the 16 human TBD agents that are reported to the CDC. In our lab, A. americanum 
and I. scapularis transcriptomes (Radulovic et al., in preparation), immuno-
transcriptomes (Radulovic et al., 2014; Lewis et al., 2015), I. scapularis and A. 
americanum saliva proteomes (Kim et al., 2016 and Kim et al., in preparation) were 
determined. In this PhD dissertation research, I have advanced our understanding of 
functional roles of some tick saliva proteins that these two medically important tick 
species inject into the host to regulate tick feeding. Results in this dissertation will lead 
to better design of anti-tick vaccine antigens. In addition to functional analysis 
associated with tick feeding events, these salivary proteins may be important in pathogen 
transmission. Thus, the overall success of this research will have broader impacts on tick 
vaccine development against tick feeding and pathogen transmission. 
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CHAPTER II 
CHARACTERIZING EFFECTS OF AMBLYOMMA AMERICANUM AND IXODES 
SCAPULARIS RECOMBINANT (R) TICK SALIVA PROTEINS (TSP) ON 
MACROPHAGE FUNCTION 
Introduction 
Hard ticks are the major vectors of many pathogens, outpacing any known 
arthropod vector. In the livestock industry, losses due to ticks and tick-borne diseases 
(TBD) are estimated in millions of US dollars (Jongejan and Uilenberg., 2004). In North 
America, many human vector-borne diseases are primarily tick borne (Nathavitharana et 
al., 2015). The USA Centers for Disease Control (CDC) lists 16 reportable human TBD 
causative agents (http://www.cdc.gov/ticks/diseases/), 13 of which are transmitted by 
hard ticks. Globally the impact of TBD in public health has been on the rise, with the 
food-for-thought article on One Health listing human TBDs among sources of human 
health concerns needing One Health solutions (Dantas-Torres et al., 2012). Seven of the 
24 vector borne disease agents that are listed by the World Health Organization 
((http://www.who.int/mediacentre/factsheets/fs387/en/) are tick borne. These include 
Crimean-Congo Hemorrhagic fever, Lyme disease, relapsing fever borreliosisis, spotted 
fever and Q fever rickettsial disease, Tick-borne encephalitis, and tularemia.  
Since there are no effective vaccines against major TBD agents, tick control 
using acaricides remains the major method to protect animals and humans against TBD 
agents (Awumbila 1996; Holdsworth 2005). Serious limitations such as environmental 
contamination and ticks developing resistance that threaten acaricide based tick control 
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have justified the need for alternative tick control methods (Graf et al., 2004; Abbas et 
al., 2014; Coles and Dryden, 2014). Immunization of animals against tick feeding has 
been validated as an alternative tick control method to solve the problems associated 
with acaricide based tick control strategies (Marcelino et al., 2012). The attraction to this 
approach is that it is environmental friendly and it is postulated to be effective against 
both susceptible and acaricide resistant tick populations. The limiting step is the 
availability of effective target antigens. With the exception of a few instances when 
human TBD infections occurred after exposure to contaminated materials (Liu et al 
2012; Annen et al., 2012; Atkinson et al., 2013; Townsend et al., 2014; Jiao et al., 2015; 
Richards 2015; Yadav et al., 2016), both animal and human TBD infections require a 
successful tick bite. From this perspective a deeper understanding of tick feeding 
physiology as a means of finding novel anti-tick targets offers promise to develop new 
tick control method has been documented (Mulenga et al., 2007; Kim et al., 2016, 
Radulovic et al., 2014; Lewis et al., 2015; Porter et al., 2015; 2016; Tirloni et al., 2014; 
2015; Ribeiro et al., 2006, Ribeiro et al., 2017; Karim and Ribeiro 2015; Garcia et al., 
2014; Karim et al., 2011; Francischetti et al., 2008; Konnai et al., 2011; Mudenda et al., 
2014; Diaz-Martin et al., 2013, de la Fuente et al., 2015). 
One of the major adaptations that make ticks successful is their immense 
capacity to suppress host defense mechanisms to tick feeding. Hard ticks accomplish 
feeding by tearing up host tissue and sucking blood that bleeds into the feeding lesion 
(Bowman et al., 1997; Wikel 1999). This feeding style provokes host defense reactions 
such as inflammation, complement activation, platelet aggregation, and blood clotting 
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that are aimed at stopping blood loss and initiating tissue repair (Ribeiro et al., 2003; 
Francischetti et al., 2002; Kazimirova 2007; Kazimirova et al., 2003; Mulenga et al., 
2001). Ticks successfully feed by secreting numerous saliva proteins that suppress host 
defenses.  
In our lab, we are interested in identification and characterization of tick saliva 
proteins (TSPs) that regulate early stages of the tick feeding process. To this end we 
have used several approaches including western blotting analysis (Mulenga and 
Khumthong 2010; Kim et al., 2015a; Ibelli e et al., 2014; Kim et al., 2015b; Kim et al., 
2016) and bio-panning of I. scapularis and A. americanum phage display cDNA 
expression libraries using antibodies to TSPs to determine tick saliva immuno-proteomes 
(Lewis et al., 2015; Kim et al., 2014). Recently we have also used Liquid 
chromatography-mass spectrometry sequencing of tick saliva proteins to identify I. 
scapularis and A. americanum tick saliva proteins that are sequentially secreted every 24 
h during blood meal feeding (Kim et al., 2016, in preparation for A. americanum). Prior 
to the start of this dissertation, several TSPs were expressed as recombinant (r) proteins 
in yeast or insect cells: published (Kim et al., 2014; Kim et al., 2015b, Radulovic et al., 
2015) and unpublished (Table 7). The goal of the second chapter of this dissertation was 
to gain insight into functional roles of selected Amblyomma americanum (n=12) and I. 
scapularis (n=3) rTSPs in tick evasion of host defense as revealed by macrophage 
functions.  
Macrophages (M) play important roles in host defense against ticks and tick 
borne infectious agents. They are important in the innate defense response and are 
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second to neutrophils to reach the infection site (Kumar and Sharma 2010). M are the 
major regulators of the inflammatory response to injury and infection, acting as a bridge 
between innate and adaptive immunity (Getz 2005). They are essential immune cells 
because they monitor the external agents through an array of cell surface receptors and 
secrete various cytokines and chemokines that direct functions of other immune cells 
(Sternberg 2006). There is evidence that M are among different immune cell types that 
infiltrate the tick feeding site (Silva et al., 2004; Boppana et al., 2005; Grigor’eva 2001) 
suggesting their involvement in tick  and host interactions. In cell culture assays, crude 
tick salivary gland extracts were demonstrated to have taxis effects on M suggesting 
that either ticks pro-actively attract this cell type to the feeding site or that the M is 
among principal cells to the host’s defense response to tick feeding (Poole et al., 2013). 
On this basis, the effects of candidate rTSPs on M function could conceivablyprovide 
insights into functional role(s) of candidate TSPs in tick feeding regulation.  
Materials and Methods 
Expression of recombinant (r) tick saliva proteins (TSP)  
 Prior to the start of this dissertation research, fifteen rTSPs were expressed using 
the pPICZ plasmid and Pichia pastoris yeast cells and the pIB/V5-His plasmid and 
Spodoptera frugiperda, Sf9 or Sf21 insect cell expression systems as described (Mulenga 
et al., 2013; Kim et al., 2014; Kim et al., 2015b, Radulovic et al., 2015). Yeast and insect 
cell-expressed rTSPs were expressed from existing yeast and insect cell stocks. For yeast 
systems, stocks were cultured at 28°C with protein expression induced by adding 5% 
methanol to cultures daily. The pPICZ plasmid and P. pastoris yeast expression system 
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secretes recombinant proteins into media. For purification, rTSPs were precipitated from 
spent media using ammonium sulfate precipitation as previously described (Mulenga et 
al., 2013; Kim et al., 2014; Kim et al., 2015b, Radulovic et al., 2015). Precipitated rTSPs 
were resuspended in appropriate buffer (1 X Phosphate Buffered Saline, 50mM Tris 
150mM NaCl or 200mM Tris, 1M NaCl, 10mM imidazole, pH 7.4) and dialyzed against 
affinity column binding buffer (200mM Tris, 1M NaCl, 10mM imidazole, pH 7.4). 
Likewise, the pIB/V5-His plasmid and Sf9 or 21 cell expression system secretes 
recombinant proteins into spent media. In the insect cell system, rTSPs were routinely 
concentrated using the using Jumbosep centrifugal spin filter devices with a 10 kD 
molecular weight cut-off point (Pall Life Sciences, Port Wahington, NY) as ammonium 
sulfate precipitation was not working well. Following concentration, insect cell 
expressed proteins were dialyzed against affinity column binding buffer (200mM Tris, 
1M NaCl, 10mM imidazole, pH 7.4). 
For both yeast and insect cell expressed rTSPs, the crude proteins was diluted with 
binding buffer and affinity purification was routinely done under native conditions using 
a Hi-trap NiCl2
+ chelating HP columns (GE Healthcare Bio- Sciences Corp, Pittsburgh, 
PA). To verify purification and background contamination, affinity purified proteins 
were resolved on a 10% SDS–PAGE gel and silver stained using standard protocols 
(detailed below). The affinity-purified proteins were then concentrated, dialyzed against 
1X PBS, pH 7.4) and stored −80°C until used for assays. Protein quantification was done 
using the Bicinchoninic acid (BCA) protein assay according to instructions by the 
manufacturer (Thermo Scientific, Wilmington, DE). Prior to use on M cells (below), 
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yeast and insect cell expressed affinity purified rTSPs were depleted of endotoxins using 
a Pierce Lal Endotoxin removal kit (Thermo Scientific, Wilmington, DE). 
Expression of rTSP in mammalian cells 
 In the preliminary screen, five of the 15 candidate rTSPs stimulated M 
(detailed below) to express pro-inflammation markers. To rule out the possibility of 
endotoxin involvement in the observed results, the five (rAamIGFBP-rP1, rAamIGFBP-
rP6 long (L), rAamIGFBP-rP6 short (S), rAAS8 and rAamTCI) rTSPs that stimulated 
M were re-expressed in Human Embryonic Kidney (HEK) mammalian cells using the 
pcDNA 3.3 expression plasmid (Thermo Scientific, Wilmington, DE). The pcDNA 3.3 
was modified (kindly provided by Dr. Mwangi) to include the CD5 secretion signal to 
allow rTSPs to be secreted into spent media (Njongmeta et al., 2012). Mature TSP open 
reading frames (ORF) were sub-cloned into the modified pcDNA plasmid using primers 
listed in Table 5. Appropriate restriction enzyme sequences were incorporated in the 
forward and reverse primers to subclone ORFs into the pcDNA 3.3 expression vector 
(Table 5). The reverse primer included the flag tag sequence and a stop codon. The flag 
tag - DYKDDDDK (where D=aspartic acid, Y=tyrosine and K=lysine) was used for 
western blotting detection and affinity purification (below). HEK-293A adherent cells 
were used for pilot expression, and the HEK-293 Freestyle (HEK-293F) cell line 
(Thermo Scientific, Wilmington, DE) was used for large-scale rTSP production in 
suspension cultures as described (Longo et al., 2013; Portolano et al., 2014). 
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Table 5 Primers for generation of mammalian expression constructs encoding pro-
inflammation rTSPs  
 
Protein ID PLASMID 
PRIMER SEQUENCES (Restriction sites underlined) 
 rAamIGFBP-rP1 pcDNA3.3 For:5-GGATCCTCGCAAGGAGTGCGGGCCTTG -3 
Rev:5-GGATCCCTACTTATCGTCATCGTCCTTGTAGTCTTTTTT 
GGGCAGCACGTTGAGCTTGG-3 
rAamIGFBP-rP6S pcDNA3.3 For:5- GGATCCTACGTCGGAACCGCACTGCG -3 
Rev: 5-GGATCCCTACTTATCGTCATCGTCCTTGTAGTCTTTTTT 
CTCGTGATGGGCCGAGTCG-3 
rAamIGFBP-rP6L pcDNA3.3 For: 5-GGATCCTACGTCGGAACCGCACTGCGAGG -3 
Rev: 5-GGATCCCTACTTATCGTCATCGTCCTTGTAGTCCTCGTG 
GTGGGCCGAGTCGCCGCCG-3 
rAamTCI pcDNA3.3 For: 5- TCAGATCTGAACGACTGCGTTTCCAACGGCTAC-3 
Rev:5AGATCTCTACTTATCGTCATCGTCCTTGTAGTCTTTTTTGTT
GAGCCACACACAGCACT-3 
AamAAS8 pcDNA3.3 For: 5- GGATCCTCAAGAGGAGCAAAAGGTGGCC-3 
Rev:5GGATCCCTACTTATCGTCATCGTCCTTGTAGTCTTTTTTGAG
GTGGTTCACTTGACCG-3 
rAamIGFBP-rP1 = recombinant Amblyomma americanum (Aam) Insulin like growth factor binding 
protein-related protein 1, IGFBP-rP6S =  Insulin like growth factor binding protein-related protein 
Short, IGFBP-rP6L = Insulin like growth factor binding protein- related protein Long, TCI = Tick 
carboxypeptidase inhibitor, AAS8 = Serine protease inhibitor. The linker (boldfaced and underlined) 
and flag tag (AAAAAAGACTACAAGGACGATGACGATAAG) were added to the reverse primers 
of IGFBP-rP1, IGFBP-rP6 S, TCI and AAS8. The BamHI site was added to both reverse and forward 
primers of IGFBP-rP1, IGFBP-rP6S, IGFBP-rP6L and AAS8. The BglII site was added to both reverse 
and forward primers of TCI.  
 
 
 
 For pilot expression of rTSPs in mammalian cells, adherent 293A cells were 
grown to a monolayer of up to ~60-70% confluence in T-75 flasks containing 10 mL of 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with glutamine and heat-
inactivated fetal bovine serum (10%) at 37°C with 5% carbon dioxide (CO2) and 85-90% 
humidity. For transfection, 1 g of plasmid DNA and 2.4 L of the transfection reagent, 
polyethyleneamine (PEI) diluted in 180 L of Opti-MEM (Thermo Scientific, 
Wilmington, DE) medium was incubated for 20 min at room temperature (RT). 
Following the incubation period, the 180 L of the plasmid DNA-PEI mixture was 
added to each plate containing the cells, mixed gently by rocking the plate, and 
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incubated for ~48 h at 37C in the humidified incubator. After 48 h, spent media was 
collected and used in an ELISA (enzyme linked immunosorbent assay) to check for 
rTSP expression using the antibody to flag tag-HRP (Horse-radish peroxidase) 
conjugated (Sigma-Aldrich, St. Louis, MO) and 3,3’, 5,5’ – tetramethylbenzidine 
substrate (Thermo Scientific, Wilmington, DE). The change in color was detected using 
an ELISA plate reader at 450 nm wavelength (Synergy H1, Biotek® microplate reader, 
BioTek Instruments, Inc., Winooski, VT, USA). The adherent cells were fixed by 100% 
ice cold methanol for 5 min at room temperature (RT). Subsequently, fixed cells were 
subjected to intracellular cell staining to detect rTSP expression using the antibody to 5 
g/mL flag tag conjugated with alkaline phosphatase enzyme (Sigma-Aldrich, St. Louis, 
MO) and substrate (Fast red TR salt, Naphthol, 10-50mM TRIS, pH-8, Sigma-Aldrich, 
St. Louis, MO).  
 For scaling up expression of rTSPs in mammalian cells, HEK-293F suspension 
cultures were grown to 1 × 106 viable cells/ml in 293 Freestyle medium (Thermo 
Scientific, Wilmington, DE) with shaking at 125 rpm in an incubator set to 8% CO2 and 
85% relative humidity. For transfection in suspension cultures, 30 g recombinant 
plasmids and 30 L of the transfection reagent, 293fectin (Thermo Scientific, 
Wilmington, DE) were incubated with 1 mL Opti-MEM media (Thermo Scientific, 
Wilmington, DE) separately. Following incubation, 293fectin and recombinant plasmids 
were combined and incubated for an additional 30 min and then added to 30 mL cell 
culture containing 30 million HEK-293F cells. The cell suspension was harvested after 
72 h and cell viability was routinely confirmed by trypan blue staining (>90% viability).  
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 After verification of rTSP expression using western blotting analysis, cell 
lysates and the supernatant were incubated with  beads conjugated with the antibody to 
the FLAG tag (Sigma-Aldrich, St. Louis, MO) overnight at 4C. The bound rTSP was 
eluted in 1 mL fractions using 0.1M Glycine buffer (pH 3.5) and neutralized with 25 L 
1M Tris-HCl (pH 8). Following verification of protein elution, fractions were combined 
and dialyzed against Tris-HCl buffer (50 mM Tris, 150mM NaCl, pH 7.4) using 10 kDa 
molecular cut off membrane spin filters (Pall Life Sciences ®, Port Washington, NY). 
SDS-PAGE and western blotting analyses 
 Routine SDS-PAGE with Coomassie blue or silver staining and western blotting 
analysis was done to confirm purification. Proteins were resolved in 10%, 12.5% and 
15% acrylamide/bis-acrylamide gels and stained with silver (Blum et al., 1966) and 
Coomassie stains (Blakesley and Boezi 1977). For western blotting analysis (Burnette 
1981), resolved proteins were transferred to a PVDF (Polyvinylidene difluoride) 
membrane using the Thermo-fisher western blot transfer system (Thermo Scientific, 
Wilmington, DE). Following transfer, membranes were blocked overnight at 4C in 5% 
skim milk in 1 X PBS-(0.05%)Tween20. Subsequently membranes were washed and 
then incubated with the antibody to the FLAG tag conjugated to HRP. The membranes 
were washed with 1 X PBS-Tween20 and the positive signal was detected using the 
chemiluminescent substrate (ECLTM Prime Western blotting detection reagent, GE 
lifesciences, Pittsburg, PA) and X-ray films or using the Chemidoc MP gel doc (Biorad, 
Hercules, CA). 
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Macrophage cell activation assay 
 The Murine RAW 264.7 macrophage (M) cell line was grown in Dulbecco’s 
Modified Eagle’s Medium (DMEM) (Lonza, Basel, Switzerland) that was supplemented 
with 4 mM L-glutamine, 4500 mg/L glucose, 1 mM sodium pyruvate, sodium 
bicarbonate, non-essential amino acid solution (Thermo Scientific, Wilmington, DE) and 
10% fetal bovine serum (FBS) (Thermo Scientific, Wilmington, DE). Cells were 
maintained at 37°C and 5% CO2, 85-90% humidity incubator. M were sub-cultured 
into 12 or 24 well plates overnight to 60-80% confluency. Routinely, the effects of 
rTSPs was investigated by co-culturing 1 x 106 M cells with 0.10, 1.0, and 10 µg/mL 
of individual or cocktail mix of rTSPs. Following 24 h incubation, cultures were 
processed for the following assays: (A) flow cytometry of cell suspensions to measure 
expression of pro-inflammation co-stimulatory markers: CD40, CD80, and CD86, (B) 
Total Nitric Oxide detection kit (Pierce Total NO Assay kit, Thermo Scientific, 
Wilmington, DE)  to determine nitric oxide (NO) in spent medium, (C) Cytokine ELISA 
assays to detect selected cytokines (TNFα, IL-1, IL-6, IL-10 and IL-12) in spent media, 
and (D) quantitative (q)RT-PCR to determine transcription of pro-inflammation and 
anti-inflammation markers, cytokines and co-stimulatory markers (primers in Table 6). 
The 24 h incubation was empirically determinedsince no or weak signals were detected 
at 8 and 12 h incubations. LPS (lipopolysaccharide), a bacterial cell wall component and 
a TLR4 (Toll like receptor) ligand (Kindly provided by Dr. Mwangi),  were used as 
positive controls and media alone served as a negative control.  
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Flow cytometric analysis of pro-inflammation co-stimulatory markers (CD40, CD80, 
and CD86)  
Treated and non-treated M were detached using PBS-1mM EDTA, centrifuged 
and re-suspended in staining medium (DMEM with sodium azide). Immuno-labeling of 
murine cell surface markers was performed by incubating cells with fluorescein 
isothiocyanate (FITC) conjugated antibodies (15 g/mL) to CD40 (Abcam, Cambridge, 
UK), CD86 (Thermo Scientific, Wilmington, DE) and CD80 (Thermo Scientific, 
Wilmington, DE) and isotype matched control mAbs IgG2a and IgG2b (Abcam, 
Cambridge, UK) for 30 min. After incubation, cells were washed three times with 
DMEM media containing 0.01% sodium azide and resuspended in 400 L 1X PBS (pH-
7.4) containing 1 g/mL propidium iodide and analyzed by flow cytometry with 
parameters set to 10,000 events, filter setting 530/30 nm wavelength (BD FACS Caliber, 
San Jose, CA) using acquisition software BD CellQuest™ (BD Biosciences, San Jose, 
CA) and the analysis program FlowJo 9.8.5 (TreeStar, Ashland, OR) at digital imaging 
core facility, Department of Veterinary Pathobiology, CVM, TAMU.  
Quantitative RT-PCR transcriptional analysis 
 Total RNA from the treated cells, positive and negative controls were isolated 
using TRizol (Thermo Scientific, Wilmington, DE). cDNA was synthesized following 
the manufacturer’s protocol (Verso cDNA synthesis kit ®, Thermo Scientific, 
Wilmington, DE) using 500 ng total RNA. The qPCR (Quantitative polymerase chain 
reaction) was performed in a 50μl final reaction mix containing specific primers (Table 
6), 1:10 diluted template cDNA, and 2X SYBR green PCR master mix (Thermo 
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Scientific, Wilmington, DE). All primers, forward and reverse were used at 300 nM 
concentration. The qPCR was performed in Applied Biosystems 7300 Real Time PCR 
System (Thermo Scientific, Wilmington, DE) and Biorad PCR machine (Biorad, 
Hercules, CA) set to the following cycling conditions thermal settings: 500C for 2 min 
for one cycle followed by 950C for 10 min, 950C for 40 cycles at 15 seconds interval and 
600C for 1 minute. The mRNA expression levels were determined by delta delta Ct 
method (Livak and Schmittgen 2001). The GAPDH (glyceraldehyde 3-phosphate 
dehydrogenase) gene was used as an endogenous control. Amplifications from non-
treated controls were used as a calibrator. The primers and concentration used in the 
study are listed in Table 6. 
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Table 6 Quantitative RT-PCR primers for pro/anti-inflammatory cytokine,  
co-stimulatory markers and signaling molecule expression 
 
Pathway TARGET PRIMER SEQUENCE  
References 
 
Pro-
inflammatory 
cytokines 
TNF- For: 5-ATGAGCACAGAAAGCATGA-3 
Rev: 5-GAATGAGAAGAGGCTGAGA-3 
Dann et al., 
2008 
IL-6 For: 5-CTCTGGGAAATCGTGGAAAT-3 
Rev: 5-CCAGTTTGGTAGCATCCATC-3 
Mazur et al., 
2015 
IL-1 For:5-CAACCAACAAGTGATATTCTCCATG-3 
Rev: 5-GATCCACACTCTCCAGCTGCA-3 
Guma et al., 
2009 
IL-12 For: 5-ATGGTGAAGACGGCCAGA-3 
Rev: 5-CAGGTCTTCAATGTGCTGGTT-3 
 
Anti-
inflammtory 
cytokine 
IL-10 For: 5-GGGAAGACAATAACTGCACC-3  
Rev: 5-GCTGGTCCTTTGTTTGAAAGA-3 
Vicente-Suarez 
et al., 2007 
Co-
stimulatory 
markers 
CD40 
For: 5-GCTATGGGGCTGCTTGTTGA-3 
Rev: 5-ATGGGTGGCATTGGGTCTTC-3 
Morgado et al., 
2014 
CD80 For: 5-CTGGGAAAAACCCCCAGAAG-3 
Rev: 5-TGACAACGATGACGACGACTG-3 
Li et al., 2016 
CD86 For: 5-CATGGGCTTGGCAATCCTTA-3 
Rev: 5-AAATGGGCACGGCAGATATG-3 
Li et al., 2016 
Signaling 
markers 
For the M1 
Macrophage 
phenotype 
NfKb-1 F: 5-GAAATTCCTGATCCAGACAAAAAC-3 
R:5ATCACTTCAATGGCCTCTGTGTAG-3 
Yamamoto et 
al., 2009 
NfKb-2 F:5-CTGGTGGACACATACAGGAAGAC-3   
R:ATAGGCACTGTCTTCTTTCACCTC-3 
Yamamoto et 
al., 2009 
RelA F:5-CTTCCTCAGCCATGGTACCTCT-3      
R:5CAAGTCTTCATCAGCATCAAACTG-3  
Yamamoto et 
al., 2009 
RelB F:5-CTTTGCCTATGATCCTTCTGC-3         R: 5-
GAGTCCAGTGATAGGGGCTCT-3  
Yamamoto et 
al., 2009 
cFos F:5-GGGGACAGCCTTTCCTACTA-3           R: 5-
CTGTCACCGTGGGGATAAAG-3 
Kim et al., 
2013 
cJun F:5-ACGACCTTCTACGACGATGC-3                                              
R: 5-CCAGGTTCAAGGTCATGCTC-3  
Kim et al., 
2013 
Internal 
control 
GAPDH For-5-TATGTCGTGGAGTCTACTGGT-3 
Rev: 5-GAGTTGTCATATTTCTCGT-3 
Davis et al., 
2013 
 
 
 
Cytokine analysis in the spent media 
 Cytokine specific ELISAs (Enzyme linked immunosorbent assay) were 
performed using Ready set go® eBioscience ELISA kits targeting IL-1, IL-6, IL-10, 
TGF and TNF according to manufacturer’s instructions (eBioscience®, Thermo 
Scientific, Wilmington, DE). Capture antibodies in 1 X coating buffer (dilution 1:250) 
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specific for IL-1, IL-6, IL-10, TGF and TNF- were coated separately on ELISA plates 
(Corning Coster® 9018, Corning, NY) with volume of 100 L in each well in triplicates 
overnight at 40C. On the following day, the plates were washed 3 times with 250 L 
wash buffer (1X PBS, 0.05% Tween 20) and blocked with ELISA diluent 
(eBioscience®, Thermo Scientific, Wilmington, DE) for 1 h at RT. Subsequently spent 
media from M cultures, 100 L/well were added to the wells in triplicate  and 
incubated for 2 h RT for binding. After incubation, the wells were washed three times 
and 100 L of detection antibody (1:250 dilution) in 1X ELISA diluent buffer. The 
plates were sealed and incubated for 1 h at RT. After 1 h, the plates were washed and 
100 L of avidin-HRP (1:25 dilution) was added and incubated for 30 min at RT. The 
plates were washed and 1X TMB (tetramethylbenzidine) was added to each well for 
enzymatic colorimetric reaction. The reaction was stopped with 50 L stop solution (2N 
H2SO4). Optical densities were measured using an ELISA plate reader at 450 nm 
wavelength (Synergy H1, Biotek® microplate reader, BioTek Instruments, Inc., 
Winooski, VT, USA). 
Nitric oxide detection 
 Nitric oxide metabolites released in the cell culture supernatant as nitrate or 
nitrite was detected by Total Nitric Oxide detection kit (Pierce Total NO Assay kit, 
Thermo Scientific, Wilmington, DE) according to the manufacturer’s protocol. Nitrate 
reductase enzyme and cofactor NADPH (Nicotinamide adenine dinucleotide phosphate) 
were added to the wells including the positive and negative control to convert nitrate to 
nitrite in the media. Finally, Griess reagent I (Sulfanilamide) and Griess reagent II (N-(1-
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Naphthyl) Ethylenediamine) was added to convert the nitrite to an Azo compound that is 
purple in color. Photometric measurement of the absorbance due to this azo 
chromophore determined the NO2
- (nitrite) concentration at 540 nm wavelength using an 
ELISA plate reader (Synergy H1, Biotek® microplate reader, BioTek Instruments, Inc., 
Winooski, VT, USA). 
Cell staining  
Based on detection of pro-inflammation co-stimulatory markers and cytokines, 
the pro-inflammation effects of the five rTSPs (AamIGFBP-rP1, AamIGFBP-rP6L, 
AamIGFBP-rP6S, AAS8, and AamTCI) on RAW 264.7 M were similar to the effects 
of LPS. To investigate similarities or differences in physical phenotypes of LPS and PI-
rTSP (AamIGFBP-rP1, AamIGFBP-rP6L, and AamIGFBP-rP6S) activated  M were 
seeded on chambered slides and immuno-stained with the antibody to Actin (Abcam, 
Cambridge, UK). Following 24 h treatment, cells were fixed with ice cold methanol, 
washed with 1X PBS and blocked with 1% BSA, 22.52 mg/ml glycine in PBST 
(PBS+0.1% Tween 20) for 30 min.  Cells were incubated with the anti-actin antibody 
overnight at 4ºC. The following day, the cells were washed in 1 X PBS and incubated 
with secondary antibody conjugated with Alexa Fluor (Abcam, Cambridge, UK) for 1 h 
in the dark. The cells were washed, treated with mounting media containing DAPI 
(Thermo Scientific, Wilmington, DE) for nuclei staining and cell staining was analyzed 
by confocal microscopy. Confocal images were acquired with Ziess LSM 780 confocal 
microscope and merged using Zen 2012 SP1 (black edition) software in the Imaging 
facility at the CVM TAMU.  
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Statistical analysis 
Data acquisition for flow cytometry was performed by using BD Cell Quest™ 
(BD Bioscience, San Jose, CA). The data analysis program used was FlowJo 9.8.5 
(TreeStar, Ashland, OR).  The  cells with >90% viability was selected by gating on the 
flow cytometer. One Way ANOVA analysis and Dunnett’s post Hoc analyses of median 
fluorescent intensities and absorbance values for cytokine and nitric secretion were done 
using PRISM software (GraphPad Software, San Diego, CA, USA) to determine 
statistical differences between the control and the treatments. The statistical significance 
of mRNA transcript abundance was determined for each replicate using the formula 2- 
ΔΔCt as described (Livak and Schmittgen, 2001).   
Results 
Amblyomma americanum secretes pro- and anti-inflammatory proteins in its saliva 
 Ticks accomplish feeding and transmission of tick borne disease (TBD) agents 
by injecting multiple tick saliva proteins (TSP) into the host to evade host defense. Prior 
to this dissertation research, our lab identified I. scapularis (Lewis et al., 2015, Kim et 
al., 2016) and A. americanum (Radulovic et al., 2014, Kim et al., in submission) TSPs 
that are sequentially injected into animals during tick feeding. Some of these TSPs were 
already expressed as recombinant (r) proteins in yeast and insect cells (Mulenga et al., 
2013, Kim et al., 2015, Radulovic et al., 2014, Ibelli et al., 2014, Kim et al., in 
preparation) (Table 7). To begin characterizing their role(s) in tick feeding regulation, 
flow cytometry was successfully used to screen the effects of 15 selected rTSP; A. 
americanum (n=12) and I. scapularis (n=3) on RAW 267.4 MΦ expression of pro-
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inflammatory co-stimulatory markers (CD40, CD80, and CD86) and nitric oxide (NO) 
secretion using the Griess assay (Griess 1879). Lipopolysaccharide (LPS), a structural 
component of gram-negative bacteria and a toll-like receptor 4 (TLR4) ligand activator 
of MΦ (Janssens and Beyaert 2003) and media only were used as positive and negative 
controls. This preliminary analysis revealed that, similar to LPS, adding various doses of 
five of the 15 tested rTSPs, A. americanum (Aam) insulin-like growth factor binding 
protein-related proteins [AamIGFBP-rP1, 0.0033 nM, 0.033 nM and 0.33 nM, 
AamIGFBP-rP6 short (S), 0.0045 nM, 0.045 nM, 0.45 nM AamIGFBP-rP6 long (L), 
0.0041 nM, 0.041 nM, 0.41 nM, A. americanum serine protease inhibitor (AAS) 8, 
0.0024 nM, 0.024 nM, 0.24 nM and tick carboxypeptidase inhibitor (TCI), 0.01 nM, 
0.10 nM, 1 nM] stimulated MΦ to express CD40, CD80, and CD86 and secrete NO 
significantly above the media negative control (Table 7). In contrast, two rTSPs, A. 
americanum serpins, rAAS27 and rAAS41 (Porter et al., 2015, Kim et al., in 
preparation, Tirloni et al., in preparation) suppressed the expression of pro-
inflammation co-stimulatory markers and NO secretion below negative control levels 
(Table 7). Five of the 15 rTSPs (asterisks marked in Table 7) that did not stimulate MΦ 
as there was less or no apparent difference from media control and were removed from 
further investigation. Furthermore, A. americanum histamine release factor (rAamHRF) 
and histamine binding proteins (AV52) that stimulated MΦ expression of the three co-
stimulatory markers at the highest dose but not at lower doses were not further 
investigated.  Here after, the five A. americanum rTSPs for which all three dosages 
stimulated MΦ to express the three pro-inflammation co-stimulatory markers and 
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secretion of NO significantly above background are referred to as pro-inflammatory (PI), 
and those that suppressed as anti-inflammatory (AI).  
 
 
 
Table 7 Preliminary analysis showing effect of Ixodes scapularis (Ixsc) and Amblyomma 
americanum (Aam and AAS) rTSPs on RAW macrophages 
 
Protein ID  PC 
(μg/ 
mL) 
PFI Percent 
NO level 
EL  
(EU/mL) 
Tick species 
CD40  CD80 CD86 
rAamIGFBP-
rP1+ 
0.1  26.20 27.47 14.43 6.88 0.05 Amblyomma 
americanum 1 28.60 20.73 14.43 0 
10 25.50 10.30 10.45 0 
rAamIGFBP-
rP6L+ 
0.1  26.23 19.68 16.49 3.94 0.27 A. americanum 
1 26.23 11.36 18.70 0 
10 21.78 18.62 13.40 0 
rAamIGFBP-
rP6S+ 
0.1  23.30 11.36 14.43 0 0.005 A. americanum 
1 26.90 21.79 18.70 0 
10 23.10 19.68 16.49 0 
rAAS8+ 0.1  28.10 16.51 10.45 1.26 0.18 A. americanum 
1 27.90 20.73 14.43 0 
10 22.90 10.30 8.54 0 
rAmTCI 0.1  20.99 0 13.25 14.33 0.01 A. americanum 
1 50.65 6.62 26.25 23.73 
10 53.02 75.49 28.50 17.82 
AV42* 0.1  17.55 0 13.25 19.05 0.037 A. americanum 
1 28.11 0 15.25 23.88 
10 10.43 0 10.25 14.97 
AV52* 0.1  0 0 0 3.72 Not done A. americanum 
1 0 0 0 3.06 
10 7.40 51.10 30.80 10.95 
AamCRT* 0.1  3.67 0 4.50 16.84 0.08 A. americanum 
1 28.11 0 0 14.86 
10 41.16 1.82 32.00 20.10 
rAamHRF* 0.1  0 0 0 1.20 0.07 A. americanum 
1 0 0 0 0 
10 14.60 26.20 17.50 9.41 
rAAS19* 0.1  0 0 0 1.42 0.01 A. americanum 
1 0.90 0 1.70 4.49 
10 0 0 1.70 7.55 
IxscS8 0.1  0 0 0 Not done 0.02 Ixodes scapularis 
1 0 0 0 Not done 
10 0 0 0 Not done 
IxscS4 0.1  0 0 0 Not done 0.28 I. scapularis 
1 0 0 0 Not done 
10 0 0 0 Not done 
rAAS27 0.1  0 22.41 (-) 0 Not done 0.00 A. americanum 
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Table 7 Continued 
 
Protein ID  PC 
(μg/ 
mL) 
PFI Percent 
NO level 
EL  
(EU/mL) 
Tick species 
CD40  CD80 CD86 
 1 1.29 (-) 24.10 (-) 3.15  Not done   
10 2.33 (-) 26.13 (-) 7.72  Not done 
rAAS41 0.1  0 24.10 (-) 0 Not done 0.0098 A. americanum 
1 9.52 (-) 9.04 (-) 0 Not done 
10 0 14.04 (-) 0 Not done 
IxscTCI* 0.1  7.29 7.10 Not 
done 
9.45 0.0136 I. scapularis 
1 0 5.59 Not 
done 
22.80 
10 3.38 7.02 Not 
done 
23.79 
PC=Protein concentration, PFI=Percent fluorescent intensity, NO = Nitric oxide, EL= Endotoxin level, 
EU= Endotoxin unit, Plus (+) sign= Insect cell expressed recombinant proteins, Tilde (~) sign = Yeast 
expressed recombinant proteins, Asterisks (*) sign = Removed from further analysis, (-) = Down-
regulated, zero (0) = not different from background. AAS = A. americanum serine protease inhibitor 
(serpin), IxscS = I. scapularis serpin. AamTCI and IxscTCI = A. americanum and I. scapularis tick 
carboxypeptidase inhibitor. 
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Mammalian cell expressed PI-rTSPs stimulated MΦ to express pro-inflammation co-
stimulatory markers (CD40, CD80, and CD86) and cytokines 
To rule out involvement of endotoxin contamination in the observed stimulation 
of MΦ by insect and yeast cell expressed PI-rTSPs (Table 7), the five PI-rTSPs 
(rAamIGFBP-rP1, rAamIGFBP-rP6S, rAamIGFBP-rP6L, rAAS8, and rAamTCI) were 
re-expressed in human embryonic kidney (HEK)-293 expression system (Fig.1). When 
co-cultured with MΦ for 24 h, all five-mammalian cell expressed PI-rTSPs stimulated 
MΦ to express CD40 significantly above media with p-values of below 0.05 (single 
asterisks [*]), 0.01 (double asterisks [**]), and 0.001 (triple asterisks [***]), respectively 
(Figs.2A). Fig.2B shows that CD80 was significantly induced in MΦ that were treated 
Negative control IGFBP-rP1 IGFBP-rP6 short IGFBP-rP6 long  Lospin 8 TCI 
Figure 1. Expression and affinity purification of pro-inflammatory tick saliva in mammalian (HEK) cells: Top panel: 
HEK cells expressing recombinant tick saliva proteins were immunostained using mouse antibody to flag tag.  Bottom panel: 
Affinity purified rTSP were subjected to SDS-PAGE electrophoresis and stained with Coommassie or silver stains.  Left to 
right: Negative control, IGFBP-rP1 (tick insulin like growth factor), IGFBP-rP6 short (tick insulin like growth factor short), 
IGFBP-rP6 long (tick insulin like growth factor long), Serine protease inhibitor 8, Tick carboxypeptidase inhibitor. 
Negative control  rAamIGFBP-rP1 rAamIGFBP-rP6L rAamIGFBP-rP6S rAamTCI rAamAAS8 
 
Figure 1. Expression and affinity purification of Amblyomma americanum (Aam) pro-
inflammation recombinant tick saliva proteins (rTSPs) in human embryonic kidney 
(HEK) 293 cells. Mature protein coding proteins were sub-cloned into modified pcDNA 
plasmids and transfected into HEK cells as described in materials and methods. Top panel: 
HEK cells expressing recombinant tick saliva proteins were immuno-stained using the 
antibody to the FLAG tag. Bottom panel: Affinity purified rTSPs were subjected to SDS-
PAGE electrophoresis on 12.5 or 15% acrylamide gels and stained with Coommassie or silver 
stains. Left to right: Negative control, rAamIGFBP-rP1 (A. americanum insulin like growth 
factor binding protein-related protein 1), resolved at approximately 30 kD, rAamIGFBP-rP6S 
(A. americanum insulin like growth factor binding protein-related protein 1), resolved at 
approx.  24 kD, rAamIGFBP-rP6L (A. americanum insulin like growth factor long), resolved at 
approx. 24 kD, rAamTCI (A. americanum tick carboxypeptidase inhibitor), resolved at 
approximately 10 kD, rAamS8 (A. americanum Serine protease inhibitor 8), resolved at 
approx. 47 kD. 
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with 0.0033 and 0.033 nM, but not 0.33 nM of rAamIGFBP-rP1, 0.0041 and 0.041, but 
not 0.41 nM of rAamIGFBP-rP6L, 0.24 but not 0.0024 and 0.024 nM of rAAS8, while 
expression in rAamTCI treated cells was minimal to negligible. In the case of CD86, 
except for 0.41 nM rAamIGFBP-rP6L and 0.45 nM rAamIGFBP-rP6S treated for which 
expression was significantly above medium control, all other treatments were 
insignificant (Fig.2C). Notable in Fig. 2 was that the lowest doses of rAamIGFBP-rP1 
and rAamIGFBP-rP6S significantly induced highest expression of CD40, and CD80 for 
the former (Fig.2A, 2B), while CD86 expression was observed at higher doses of all five 
rTSPs (Fig. 2C). Although treatment of MΦ with PI-rTSPs induced nitric oxide above 
medium control, it was not statistically significant (Fig.2D) 
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Motivated by the fact that activated MΦ that were expressed pro-inflammation 
co-stimulator markers are characterized by secretion of a range of cytokines (Duque and 
Descoteaux 2014), quantitative (q) RT-PCR (primers in Table 6) and cytokine ELISA 
were conducted to determine effects of PI-rTSP on MΦ expression of pro-inflammatory 
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Figure 2. Mammalian cell expressed pro-inflammation (PI)-rTSPs stimulate MΦ to express 
pro-inflammation co-stimulatory markers and nitric oxide (NO). RAW macrophages were 
co-cultured with rAmIGFBP-rP1 (0.0030 nM, 0.030 nM, 0.30 nM), rAmIGFBP-rP6L (0.0041 
nM, 0.041 nM, 0.41 nM), rAmIGFBP-rP6S (0.0045 nM, 0.045 nM, 0.45 nM), rAAS8 (0.0024 
nM, 0.024 nM, 0.24 nM), rAamTCI (0.01 nM, 0.10 nM, 1 nM) rTSPs for 24 h. LPS was used 
positive. Data is represented as fold change of treatments above negative control (Treatment 
median fluorescent intensity (MFI)/negative control MFI for cell surface marker detection and 
Treatment absorbance/negative control absorbance for NO detection). Data are reported as the 
mean (three biological replicates) ± SE of three replicates. (*) = p ≤ 0.05, (**) = p ≤ 0.01, (***) = 
p ≤ 0.001, (****) = p ≤ 0.0001, indicating statistically significant difference between media and 
treatments using one way ANOVA followed by post hoc Dunnett’s multiple comparisons test. 
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cytokines, IL-1, IL-6, IL-12, and TNF-α, and the anti-inflammatory cytokine, IL-10 (Fig. 
3). Quantitative RT-PCR revealed that the TNFα transcript was expressed significantly 
above background in MΦ that were treated with 0.033 nM rAamIGFBP-rP1, 0.41 nM 
rAamIGFBP-rP6L, and all three doses of rAamTCI (Fig.3A). Similarly the IL-6 
transcript was expressed above background in MΦ that were treated with 0.033 nM 
rAamIGFBP-rP1 and 0.041 nM rAamIGFBP-rP6L, but not in other treatments (Fig.3B). 
Likewise cytokine ELISA revealed that TNF-α, but not other cytokines were secreted at 
levels there were significantly above media control (Figs.3C). As shown in Fig.3C, 
TNF-α was secreted in significant amounts by MΦ that were treated with 0.33 nM 
rAamIGFBP-rP1 (p0.0001), 0.041 nM rAamIGFBP-rP6L (p0.0001), 0.024 nM 
(p0.05) and 0.24 nM (p0.0001) rAAS8. In the case of IL-6, except for MΦ that were 
treated with 0.24 nM (p0.001) rAAS8, levels in other treatments were apparently 
higher or insignificant (Fig.3D). It is interesting to note that the highest expression levels 
of TNF-α secretion was in MΦ that were co-incubated with low doses of rAamIGFBP-
rP6L (0.041 M) and the highest dose of rAamIGFBP-rP1 (Fig. 3C). Given the low 
expression levels of rAAS8 and rAamTCI in mammalian cells (Fig.1), further analysis of 
these two proteins was not pursued.  
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Figure 3. Mammalian cell expressed pro-inflammation (PI)-rTSPs stimulate MΦ to express 
pro-inflammation cytokines. RAW macrophages were co-cultured with rAmIGFBP-rP1, 
rAmIGFBP-rP6L, rAmIGFBP-rP6S, rAAS8, rAmTCI rTSPs for 24 h. LPS was used positive control 
and culture media only as negative control. Cells and spent media were harvested and respectively 
subjected to quantitative expression analysis of PI cytokines TNFα and IL-6 (Fig.3A, B), GAPDH 
was used as internal reference and Media only was used as calibrator, ELISA to detect secretion of 
PI cytokines (Fig.3C, D) as described. Concentrations rAmIGFBP-rP1 (0.0030 nM, 0.030 nM, 0.30 
nM), rAmIGFBP-rP6L (0.0041 nM, 0.041 nM, 0.41 nM), rAmIGFBP-rP6S (0.0045 nM, 0.045 nM, 
0.45 nM), rAAS8 (0.0024 nM, 0.024 nM, 0.24 nM), rAamTCI (0.01 nM, 0.10 nM, 1 nM) rTSPs 
were used. Data are reported as the mean (three biological replicates) ± SE of three replicates. (*) = 
p ≤ 0.05, (**) = p ≤ 0.01, (***) = p ≤ 0.001, (****) = p ≤ 0.0001, indicating statistically significant 
difference between media and treatments using one way ANOVA followed by post hoc Dunnett’s 
multiple comparisons test. 
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As AamIGFBP-rP1, rAamIGFBP-rP6S, and rAamIGFBP-rP6L are structurally 
(Mulenga et al., 2010) and functionally similar as insulin binding proteins (Radulovic et 
al., 2014, Radulovic et al., in preparation for AamIGFBP-rP6S and AamIGFBP-rP6L) 
and the fact that all three proteins have similar secretion kinetics during A. americanum 
tick feeding (Kim et al., in preparation), I proceeded to analyze the effects of these 
proteins as a cocktail mix to investigate the possibility for synergy. It was interesting to 
note that the cocktail of the three PI-rTSPs (AamIGFBP-rP1, AamIGFBP-rP6S, and 
AamIGFBP-rP6L) were synergistic in that secretion levels of TNF-α, IL-1, and IL-6 
were similar to those detected in spent media of LPS treated MΦ (Fig. 4A-C). 
Interestingly, detectable amounts of anti-inflammation cytokines IL-10 and TGF were 
also present in spent media of these MΦ (Fig. 4D, E). Given similarities in cytokine 
expression levels between LPS and PI-rTSP activated MΦ, the potential for any 
similarities in physical attributes was investigated through staining. Staining with the 
Alexa Fluor labeled antibody to actin revealed that the physical phenotypes of LPS and 
PI-rTSPs activated MΦ were comparable as indicated by spindle formation (Fig.4F). 
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Co-incubating LPS and PI-rTSP activated MΦ with rAAS27 and rAAS41 reverses 
expression of pro-inflammation markers 
 In preliminary studies, the expression levels of co-stimulatory molecules; CD40, 
CD80, and CD86 were detected below background in MΦ treated with either rAAS27 or 
rAAS41 (Table 7). This suggested two possibilities: either that the two serpins (i) 
prevented activation of, or (ii) selectively affected functions of activated MΦ. The first 
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Figure 4. The cocktail mix of pro-inflammation (PI) rTSPs: rAamIGFBP-rP1, 
rAamIGFBP-rP6S, and rAamIGFBP-rPL6L synergistically stimulated MΦ to express 
high levels of pro-inflammation cytokines and anti-inflammation cytokines. RAW 
macrophages were treated with PI-rTSPs as described. (Fig4A-4E) supernatants from the 
treatments were collected following 24 h incubation for detection of cytokine TNFα, IL-1, 
IL-6, IL-10 and TGFβ using cytokine ELISA kits. Data are reported as the mean (three 
biological replicates) ± SE of three replicates and represented as fold change of treatments 
above negative control (Treatment absorbance/negative control absorbance). (*) = p ≤ 0.05, 
(**) = p ≤ 0.01, (***) = p ≤ 0.001, (****) = p ≤ 0.0001, indicating statistically significant 
difference between media and treatments using one way ANOVA followed by post hoc 
Dunnett’s multiple comparisons test. (Fig.4F) MΦ that were stimulated with PI-rTSPs were 
fixed with 100% methanol, incubated with 1% BSA, 22.52 mg/mL glycine PBST (PBS-
Tween) blocking solution for 1 h. The cells were incubated overnight at 4º C with the 
primary antibody (Ab), goat anti-mouse actin antibody. Following appropriate washing of 
non-specifically bound Ab, MΦ were incubated with the secondary antibody conjugated 
with Alexa fluor for 30 min at room temperature. Nuclear DNA was labeled with DAPI 
(shown in blue). Images were captured using confocal microscope. PI1, PI2, and PI3 = 0.1, 
1.0, and 10 g of the PI-rTSP cocktail.  
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possibility was ruled out in that co-incubating MΦ with rAAS27 or rAAS41 individually 
or as a cocktail did not impact expression levels of co-stimulatory markers or cytokines 
(not shown). To investigate the second possibility, MΦ were first activated with LPS 
(100 ng) or various dosages (0.1, 1, 10 g) of rAamIGFBP-rP1, or rAamIGFBP-rP6L, 
and rAamIGFBP-rP6S (PI) for 24 h and then replacing culture media with fresh media 
that contained various dosages (0.1, 1, 10 g) of rAAS27 and rAAS41 or the cocktail of 
both proteins for an additional 24 h. Individually, rAAS27 or rAAS41 had modest 
effects on expression of co-stimulatory markers in LPS activated MΦ (not shown). 
However, the rAAS27 and rAAS41 cocktail had a much more dramatic effect on LPS 
activated MΦ as analyzed by flow cytometry using staining for the various CD markers 
(Fig.5). Adding various dosages of the rAAS27 and rAAS41 cocktail on MΦ that were 
activated with LPS, reduced the expression levels of CD40, CD80 and CD86 by 43-
48%, 16-28%, and 10-13% respectively (Fig.5A and inserts). Likewise, albeit at low 
levels, co-incubating PI-rTSPs activated MΦ with the rAAS27 and AAS41 cocktail 
respectively reduced the expression of CD40 and CD80 by ~6-8.5% and ~12-13%, while 
CD86 expression by less than 3% (Fig.5B and inserts).  
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Figure 5. Amblyomma americanum anti-inflammation (AI)-rTSP reverses the 
expression of costimulatory markers by LPS and A. americanum pro-inflammation 
(PI)-rTSP activated macrophages. RAW macrophages (MΦ) were cultured in the 
presence of LPS (Fig.5A) or with various doses of PI-rTSPs as noted (Fig.5B) for 24 h. 
Subsequently culture media was replaced with media that contained various doses of AI-
rTSPs as noted for an additional 24 h for both LPS and PI-rTSP activated cells. 
Subsequently cells were harvested and immuno-stained with FITC conjugated antibody to 
CD40, CD80 and CD86 and analyzed by Flow cytometry. Filled gray chromatogram = 
isotype control, dark gray line chromatogram and bar graph = media treated cells, blue 
line chromatograms and bar graphs = LPS or PI-rTSP pre-activated MΦ co-incubated with 
AI-rTSPs, red chromatogram and bar graph = LPS or PI-rTSP activated MΦ only. Bar 
graph inserts show mean median fluorescent intensity in MΦ that were treated with LPS 
or PI-rTSP only (red bars), media only (gray bars), and LPS or PI-rTSP followed by AI-
rTSP.  
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Figure 5 Continued 
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While individual rAAS41 and rAAS27 did not affect the expression of co-
stimulatory markers by LPS activated MΦ (not shown), it was notable that adding 0.024 
and 0.24 nM rAAS27 and rAAS41 to LPS activated MΦ respectively reduced transcript 
abundance of pro-inflammation cytokines, TNFα and IL-1 by 7-11% and 12-33% but 
not IL6 (Fig. 6A, B). Likewise, spent media of these MΦ contained reduced amounts of 
TNFα, IL1, and IL6 (Figs.6C, D, E). We observed comparable results when LPS 
activated MΦ were co-incubated with rAAS41 for which we determined that transcript 
abundance of TNFα and IL-1 and not IL-6 were suppressed respectively (Fig. 6F-G).  
Cytokine ELISA revealed that rAAS41 treatment of LPS activated MΦ reduced 
secretion of TNFα, IL-1 and IL-6 respectively (Fig.6H, I, J). On the other hand, co-
incubating the AI-rTSP cocktail with MΦ that were pre-activated with PI-rTSP did not 
affect cytokine transcription (not shown). Fig.7 demonstrates that the effects of the AI-
rTSPs cocktail on LPS and PI-rTSPs activated MΦ secretion of cytokines was mixed. 
Except for TNF, which was dose dependently suppressed (Fig.7A T1), AI-rTSPs 
treatment did not affect secretion levels of cytokines MΦ that were pre-activated with 
LPS (Fig.7B-7E, T1).  
Similarly, AI-rTSP treatment of MΦ that were pre-activated with PI-rTSP did not 
affect cytokine secretion of TNF, IL1, IL6, and IL-10 (Figs.7B-7D, T3 vs T4). It is 
notable that whereas adding AI-rTSP cocktail did not have any effects on TGF 
secretion in LPS activated MΦ, it was interesting to note that this treatment significantly 
induced secretion of TGF in MΦ that were pre-activated with PI-rTSPs (Fig7E, T3 vs 
T4).  
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Figure 6. Amblyomma americanum anti-inflammation (AI)-rTSP, rAAS27 and rAAS41 
reverses the expression of pro-inflammation cytokines by LPS activated macrophages. RAW 
macrophages (MΦ) were cultured in the presence of LPS for 24 h. Subsequently culture media was 
replaced with media that contained various doses of AI-rTSPs as noted for an additional 24 h. Cells 
and spent media in three biological replicates were processed to respectively determine 
transcription and secretion levels of cytokines TNFα, IL1 and IL6 using ELISA and qRT-PCR, 
GAPDH was used as internal reference and Media only was used as calibrator. rAAS27 
concentrations, 0.00239, 0.0239, and 0.239 nM, rAAS41 concentrations, 0.00239, 0.0239, and 
0.239 nM were used respectively.  Data is represented as fold change: Treatment absorbance 
values/media control absorbance values and reported as the mean (three biological replicates) ± SE 
of three replicates. (*) = p ≤ 0.05, (**) = p ≤ 0.01, (***) = p ≤ 0.001, (****) = p ≤ 0.0001, 
indicating statistically significant difference between media and treatments using one way ANOVA 
followed by post hoc Dunnett’s multiple comparisons test. 
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Figure 7. Amblyomma americanum anti-inflammation (AI)-rTSP, rAAS27 and rAAS41 
cocktail mix reverses TNFα and enhances TGFβ expression, but did not affect 
expression of other pro-inflammation cytokines in macrophages that were pre-
activated with LPS or the PI-rTSP cocktail (rAamIGFBP-rP1, rAamIGFBP-rP6S, and 
rAamIGFBP-rPL6). RAW macrophages were cultured for 24 h with 100 ng/µL LPS 
(marked as T1) or various doses of the PI-rTSP cocktail (T2-T4). The secretion levels of 
cytokines; TNF-α, IL-1, IL 6, TGFβ and IL-10 in spent media was determined by ELISA. 
Data are reported as the mean (three biological replicates) ± SE of three replicates and 
represented as fold change of treatments above negative control (Treatment 
absorbance/negative control absorbance). FI = cells incubated for 24 h with indicated 
treatments. SI = remove 24 h spent media, and continue to incubate with fresh media 
containing indicated reagents. LPS = 100 ng LPS, M = Media only, PI = pro-inflammation 
protein cocktail of rAamIGFBP-rP1, rAamIGFBP-rP6L, rAamIGFBP-rP6S. PI1, PI2, and 
PI3 = 0.1, 1 μg, and 10 μg of the PI cocktail. AI = anti-inflammation protein cocktail of 
rAAS27 and sAAS41. AI1, AII2, and AI3 = 0.1, 1 μg, and 10 μg of the AI cocktail.  T1, T2, 
T3, T4 and T5 represents each experiment.  
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PI-rTSPs activate MΦ via TLR4 and cytokine signaling pathways 
The observation that PI-rTSP stimulated MΦ to express high levels of co-
stimulatory markers, pro-inflammation cytokines, and secretion of NO fit the phenotype 
of classically activated (or M1) MΦ (Martinez and Gordon 2014). Alternatively, 
induction of anti-inflammatory cytokines by AI-rTSPs suggest that these proteins might 
have induced alternatively activated (or M2) MΦ, which have anti-inflammatory 
phenotype (Roszer 2015). As M1 MΦ were activated via the TLR4 or cytokine receptor 
signaling pathways (Italiani and Boraschi 2014), expression of signaling markers for 
these two pathways was investigated (Fig.8). Data in Fig.8 demonstrates that the three 
PI-rTSPs may activate MΦ via the TLR4 and cytokine signaling pathways. Except for 
NFB1 (Fig.8A), three, NFB2, RelA, and RelB (Fig.8B, 8C, and 8D) of the four tested 
TLR4 signaling markers and two cytokine signaling, cFos and cJun (Fig.8E and 8F) 
were differentially up regulated in a dose responsive manner when MΦ were co-
incubated with various dosages of the PI-rTSP cocktail. Interestingly, adding AI-rTSPs 
to these MΦ suppressed NFkB transcript levels by more than 50% (Fig.8A) and slightly 
for other markers. Additionally, AI-rTSP cocktail induced significant secretion of the 
anti-inflammation cytokine, TGF and IL10 to MΦ that were pre-activated with PI-
rTSP. This was also confirmed when qRT-PCR analysis of markers for the anti-
inflammation M2 MΦ was significantly induced (Fig.8).  
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Discussion  
Feeding success and competence of hard ticks to transmit tick borne disease 
(TBD) agents depends on multiple tick saliva proteins (TSP) that are injected into the 
host to evade host defense to tick feeding. Thus, discovery and determining functional 
roles of TSPs in tick feeding regulation is highly sought after as it will likely reveal 
critical proteins that will be targeted for development of novel methods to prevent 
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Figure 8. The pro-inflammation (PI)-rTSP (rAamIGFBP-rP1, rAamIGFBP-
rP6S, and rAamIGFBP-rPL6) cocktail induced expression of markers for pro-
inflammatory macrophage activation. Macrophages were cultured in medium 
containing with various doses of the PI-rTSP cocktail only (PI) or the PI-rTSP and 
anti-inflammation (AI)-rTSP cocktail (PIAI). Cells were processed for qRT-PCR 
analysis using primers in Table 6. Transcript abundance of markers for pro-
inflammatory macrophage activation, NFκB1 (Nuclear factor kappa light chain 
enhancer of activated B cells), NFκB2, RelA (Transcription factor p65 or Nuclear 
factor kappa B p65) , RelB, Activator protein molecules: cFos and cJun was 
determined by qRT-PCR as descibed. GAPDH was used as internal reference and 
Media only was used as calibrator. Data is presented as fold increase and/or decrease 
from the media as the mean ± SE of three biological replicates. (*) = p ≤ 0.05, (**) = 
p ≤ 0.01, (***) = p ≤ 0.001, (****) = p ≤ 0.0001, indicating statistically significant 
difference between media and treatments using one way ANOVA followed by post 
hoc Dunnett’s multiple comparisons test. PI1, PI2, and PI3 = 0.1, 1.0, and 10 μg of 
PI-rTSPs. PI1AI1, PI2AI2, and PI3AI3 = 0.1, 1.0, and 10 μg each of the PI- and AI-
rTSP cocktails combined.  
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transmission of TBD agents (Simo et al., 2017; Ribeiro et al., 2017; Karim and Ribeiro 
2015; Garcia et al., 2014; Karim et al., 2011; Francischetti et al., 2008; Konnai et al., 
2010; Mudenda et al., 2014; Diaz-Martin et al., 2013). To this end, several approaches 
including immuno-screening of cDNA expression libraries (Mulenga et al., 1999; 
Ribeiro et al., 2006; Schwarz et al., 2014; Schwarz et al., 2013; Kotysfakis et al., 2015), 
biopanning of phage display cDNA expression (Radulovic et al., 2014, Lewis et al., 
2015), and LC-MS/MS sequencing of proteins in tick saliva and tick cement (Hollman et 
al., in press; Kim et al., 2016, Tirloni et al., 2014; 2015, Vora et al., 2017, Bullard et al., 
2016) were used to identify proteins that ticks inject into animals during feeding. The 
goal of the second chapter of this dissertation was to gauge insight into functional role(s) 
of 15 selected TSPs in tick feeding regulation.  
The majority of published studies to understand how TSPs regulate the tick’s 
evasion of host defense have involved assessing effects of crude salivary gland extracts 
(SGE) or defined rTSPs on immune cells that are pre-activated with mitogens such as 
the lipopolysaccharide (LPS), concanavalin (ConA), pokeweed (PWM), and 
phytohaemagglutinin (PHA) (Wikel et al., 1996;  Cavassani et al., 2005; Kovar et al., 
2001; Inokuma et al., 1998) or are pathogen activated (Banajee et al., 2016; Hermance 
and Thangamani 2015). Most of these studies have reported immunosuppressive effects 
in tick saliva. For instance, saliva of Amblyomma variegatum impaired the mobilization 
of inflammatory monocyte derived cells (Vachiery et al., 2015), while R. microplus 
saliva suppressed LPS activated MΦ expression of co-stimulatory markers including 
CD86 and CD69, but not CD40 and CD80 (Brake et al., 2010). The same authors found 
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that R. microplus salivary gland extracts suppressed MΦ secretion of pro-inflammatory 
cytokines. In another study  of D. variabilis crude SGE inhibited migration of MΦ into 
the tick feeding site (Poole et al., 2013). In a related study, SGE of D. variabilis 
inhibited LPS activated MΦ secretion of pro-inflammatory cytokines (Poole et al., 
2013). In this dissertation a different approach was utilized, investigating the direct 
effects of 15 recombinant (r)TSPs on MΦ function. This approach was based on the facts 
that: (a) not every tick bite is infectious, and (b) with the exception of some viruses 
(Hermance and Thangamani 2015), transmission of major tick-borne disease (TBD) 
agents predominantly occurs after ticks have fed for more than 48 h (Richards et al., 
2017). Additionally, the infiltration of immune cells into the tick feeding site that starts 
within 24 h of tick attachment (Krause et al., 2009), precedes transmission of major TBD 
pathogens such as Babesia bovis and B. bigemina (Mahoney and Mirre 1977; Hodgson 
1992), Erhlichia ruminantium (Uilenberg et al., 1993), Borrelia burgdorferi (Burgdorfer 
1984), and Anaplasma phagocytophilum (Ogden et al., 2003), which are predominatly 
transmitted after the tick has fed for more than two days. From this perspective, there is 
likely an initial period during which immune cells are exposed to TSPs in the absence of 
TBD agents.  
The macrophage (MΦ) is an important immune cell that plays key roles in 
regulating both innate (Fujiwara and Kobayashi 2005; Medzhitov and Janeway 1997; 
Parihar et al., 2010) and adaptive immunity (Scholl et al., 2016; Chen et al., 2012).  
Additionally, there is evidence that MΦ are associated with the tick feeding site as 
revealed by immunohistochemical staining of the tick feeding site that showed that MΦ 
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and other immune cells infiltrate the tick feeding site (Krause et al., 2009). On this basis, 
the observed effects of rTSPs on the function of MΦ could sufficiently be informative on 
roles of TSPs in tick feeding regulation. The functional roles of MΦ fall within a 
spectrum that is bordered by classically activated pro-inflammatory M1 MΦ and the 
alternatively activated anti-inflammatory M2 MΦ (Martinez and Gordon 2014). M1 MΦ 
are characterized by expression of pro-inflammation markers such as co-stimulatory 
markers CD40, CD80, and CD86 and cytokines, and secretion of nitric oxide (NO). The 
other phenotype is the alternatively activated M2 MΦ that are characterized by high 
expression of anti-inflammation cytokines that include IL-10 and TGF (Carreno and 
Collins 2002; Fujiwara and Kobayashi 2005). Expression of co-stimulatory markers on 
M1 MΦ is critical in shaping the extent and nature of immune response (Khan et al., 
2012), which transforms MΦ to dendritic like cells to produce pro-inflammatory 
mediators TNFα, IL-6 and IL1 (Duque and Descoteaux 2015). TNFα is a pro-
inflammation pleotropic cytokine that is important in fibroblast growth, adaptive 
immune response, T lymphocyte response, vasodilation and lymphocyte, neutrophil and 
monocyte infiltration during inflammation (Paraneswaran and Patial 2010). IL-6 is a key 
B cell and Th17 differentiation factor (Fernando et al., 2014). The interaction of B7 
ligands CD80 (B7.1) and CD86 (B7.2) with their receptors are not only act as activation 
markers, they provide the most potent costimulatory signal for T cell activation 
(Salomon and Bluestone, 2001). CD80 expression correlates with the development of 
Th1 cells and CD86 expression favors the generation of Th2 cells (Kuchroo et al., 1995). 
Thus, the observation that similar to LPS, five A. americanum TSPs including 
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rAamIGFBP-rP1, rAamIGFBP-rP6S, rAamIGFBP-rP6L, rAAS8, and rAamTCI, 
stimulated MΦ to express co-stimulatory molecules, CD40, CD80, and CD86 in fig. 2 
and pro-inflammatory cytokines, TNFα and IL-6 in fig. 3 indicated that these five rTSPs 
were pro-inflammatory (PI). On the other hand, two rTSPs, rAAS27 and rAAS41, which 
did not affect resting MΦ, but reversed LPS or PI-rTSPs activated MΦ were classified as 
anti-inflammatory (AI) proteins (Fig. 5-7). As endotoxins can stimulate MΦ into 
expression of pro-inflammation markers (Sweet and Hume 1996), there was a chance 
that the observed data was due to endotoxin contamination. This was ruled out in that 
both mammalian cell expressed PI-rTSPs devoid of endotoxin contamination as well as 
insect cell expressed PI-rTSPs stimulated MΦ to express pro-inflammation co-
stimulatory markers (CD40, CD80, and CD86) and cytokines, TNFα, IL-6, and IL-1, and 
secretion of NO.  
Our lab previously showed that AamIGFBP-rP1, AamIGFBP-rP6S, and 
AamIGFBP-rP6L are structurally (Mulenga et al., 2013) and functionally similar as 
insulin binding proteins (Radulovic et al., 2014). In a related study, A. americanum tick 
saliva proteome analysis revealed that AamIGFBP-rP1, AamIGFBP-rP6S, and 
AamIGFBP-rP6L have a similar secretion pattern (Kim et al., in preparation) during tick 
feeding. Thus, it was interesting to note that secretion levels of pro-inflammation 
cytokines were enhanced in MΦ that were treated with AamIGFBP-rP1, AamIGFBP-
rP6S, and AamIGFBP-rP6L cocktail suggesting these three PI-rTSPs had a synergistic 
pro-inflammatory effect. It is important to note that whereas individual PI-rTSPs did not 
stimulate expression of anti-inflammation cytokines, expression of anti-inflammation 
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cytokines, IL-10 and TGF was induced at high dosage of the PI-rTSP cocktail mix. 
This observation could be explained by the fact that at high dosage, the PI-rTSP cocktail 
over activated MΦ, which in turn triggered expression of anti-inflammation cytokines. 
There is evidence that an intense inflammation response is curtailed by expression of 
anti-inflammation cytokines including IL-10 and TGF to prevent destruction of self 
tissue (Deng et al., 2012, Sica and Mantovani  2012). Its most likely that the amount of 
PI-rTSPs that are injected into the host during tick feeding will be lower than amounts 
used in this study. On this basis, the observed expression of anti-inflammation cytokines 
at the high PI-rTSP cocktail dose may not be a physiological event.  
In addition to inducing immune cell influx into the site of injury, inflammation 
also promotes blood flow to the site of injury through vasodilation and increased leakage 
of blood vessels (Freire and Dyke 2013). This actions would also result in increased 
blood flow to the tick feeding site. Thus, it is possible that the five PI-rTSPs described in 
this dissertation could be facilitating blood meal feeding through enhanced blood flow to 
the feeding site. Likewise, TNF which was secreted at high levels in MΦ that were 
activated with individual PI-rTSP or cocktail mix of AamIGFBP-rP1, AamIGFBP-rP6S, 
and AamIGFBP-rP6L was shown to promote blood flow to the site of injury (Naredi et 
al., 1993; Farkas et al., 2006).  
As the tick is expected to suppress the host’s inflammatory response to 
successfully feed and transmit TBD agents (Wu et al., 2010; Glatz et al., 2017; Simo et 
al., 2017), data in this dissertation which showed that A. americanum PI-rTSPs promoted 
inflammation was counter-intuitive. However, data presented here is not unique to this 
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study as pro-inflammation activities have been previously documented in tick saliva. A 
functional tick histamine release factor (Mulenga et al., 2003) was suspected to promote 
inflammation through release of histamine, an agonist for acute inflammation (Benly 
2015). Likewise, a serine protease 84 kDa inducer of immediate hypersensitivity in 
naïve rabbits was purified from Haemaphysalis longicornis (Mulenga et al., 2001). In a 
recent study, Powassan virus infected I. scapularis ticks induced expression of markers 
for inflammation during the first 2 h of feeding on mice (Hermance and Thangamani 
2015).  
We expected ticks to suppress host defense (Kazimirova and Štibrániová 2013; 
Wikel 2013). Thus, the observation that rAAS27 and rAAS41 reversed the expression of 
pro-inflammation markers by both LPS and PI-rTSPs stimulated MΦ was not surprising. 
Several studies have reported tick immune-suppressive effects (Kotysfakis et al., 2006; 
Oliveira et al., 2008; Guo et al., 2009; Langhansova et al., 2015; Wang et al., 2016; 
Chmelar et al., 2011). However, the observation was that both rAAS27 and rAAS41 did 
not act on resting MΦ, but they acted on pre-activated MΦ was interesting. Another 
notable observation was that co-incubating the rAAS27 and rAAS41 cocktail with MΦ 
that were pre-activated with either PI-rTSPs, but not LPS, enhanced secretion of TGF 
anti-inflammation cytokine. From the perspective of TBD transmission, the observation 
that rAAS27 and rAAS41 likely acted on pre-activated MΦ is interesting. TBD agents 
such as Ehrlichia chaffeensis and most tick-borne viruses (TBV) target and activate MΦ 
to express pro-inflammatory cytokines (Miura et al., 2011; Hermance and Thangamani 
2014; Scholl et al., 2016). Studies have shown that activated MΦ can limit proliferation 
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of TBV (Tick borne virus), such as tick-borne encephalitis (Ahantarig et al., 2009). 
Could it be possible that AAS27 and AAS41 could act on tick borne disease (TBD) 
agents activated MΦ to control the killing of TBD agents, and as a consequence enhance 
transmission? 
LPS, which was used as the positive control in this research activates MΦ toward 
the M1 phenotype via the toll-like receptor (TLR)4 (Lu et al., 2008). The observation 
that similar to LPS, treatment of MΦ with PI-rTSPs induced expression of  markers for 
TLR4 signaling could suggest that tick induced inflammation may be mediated via the 
TLR4 pathway. It is also possible that PI-rTSPs could have have mediated MΦ 
activation via the cytokine signaling pathway, which intersects with TLR4 signaling 
pathway.   
In conclusion, this second chapter shows that A. americanum ticks secretes two 
types of saliva proteins: (i) those that promote inflammation here referred to as PI-
rTSPs, and (ii) those suppress inflammation, here called as anti-inflammatory, AI-rTSPs. 
Based on findings in this chapter, I propose a scenario of where both PI-rTSPs and AI-
rTSPs are part of the tick’s mechanism to evade host defense. Although I used RAW 
macrophages, which do not mimic primary cell function, I speculate that, the tick may 
utilize a strategy that is similar to the “bait and switch” mechanism on host 
macrophages, of where PI-rTSPs activate MΦ, and AI-rTSPs dampen those activated 
MΦ to where their effect in directing the host’s response to tick feeding does not proceed 
as intended.  
Overall, findings in this second chapter advances our understanding of how ticks 
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may evade host defense. The discovery of defined TSPs that interact with MΦ adds to 
the complexity of tick feeding physiology. As this second chapter was cell culture based, 
I proceeded to investigate if both AI- and PI-rTSP described in this second chapter were 
functional in vivo in the third chapter. 
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CHAPTER III 
VALIDATE IN-VIVO FUNCTIONS OF IN-VITRO VALIDATED PRO/ANTI-
INFLAMMATORY RECOMBINANT TICK SALIVA PROTEINS 
Introduction 
In chapter II of this dissertation, an in vitro cell culture based analysis investigated 
the effect of 15 recombinant tick saliva proteins (rTSPs) on murine RAW 264.7 
macrophage (M) expression of pro-inflammation co-stimulatory markers, CD40, 
CD80, and CD86, pro-and anti-inflammation cytokines, and secretion of nitric oxide. 
This analysis identified five rTSPs (AamIGFBP-rP1, AamIGFBP-rP6S, and AamIGFBP-
rP6L, AAS8, and AamTCI) that were classified as pro-inflammation (PI) rTSPs as they 
stimulated M to express pro-inflammation co-stimulatory markers and cytokines. Two 
other rTSPs, rAAS27 and rAAS46 were classified as anti-inflammatory (AI) as they 
reversed the expression of pro-inflammation markers in both LPS and PI-rTSP activated 
M. In a separate study, our lab has determined that both PI- and AI-rTSPs that were 
characterized in the second chapter are injected into animals during tick feeding (data 
not shown). The goal of this second chapter was to determine if cell culture validated PI- 
and AI-rTSP were functional in vivo using the mouse hind paw edema assay (Winter et 
al., 1962). 
 Paw or footpad swelling was first used as convenient method for assessing 
inflammatory responses more than 50 years ago (Winter et al., 1962). This approach is 
now a routine method to demonstrate functionality of both agonists (Vajja et al., 2004, 
Morris 2003, Waisberg et al., 2014) and antagonists (Oyanagui et al., 1991; Hassimotti 
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et al., 2013) for inflammation. Our lab and our collaborators in Brazil, used paw edema 
to demonstrate that rAAS27 and AAS41 individually blocked formalin and compound 
48/80 induced inflammation in rats (Kim et al., in preparation, Tirloni et al., in 
preparation). In this third chapter of the dissertation, the effects of rAAS27 and rAAS41 
on PI-rTSP induced inflammation in an in-vivo foot pad swelling assay was investigated.  
Materials and Methods 
Paw edema assay 
The paw edema assay was performed as previously described (Winter et al., 1962) 
using female retired breeder BALB/c mice (Envigo, Huntingdon, UK). Animals were 
housed and cared for under humane conditions according to the approved animal use 
protocol (#2015-0079) by Texas A&M University Institutional Animal Care and Use 
Committee (IACUC) under pathogen free conditions in temperature controlled rooms, 
receiving water and food ad libitum. Edema progression was studied by measuring the 
baseline thickness of the hind footpads using plythesmometer (Harvard Apparatus, 
Holliston, MA). Four experiments were conducted. Groups of three mice was used in all 
four experiments (Table 8).  In the first experiment, combinatorial effect of PI-rTSPs 
were assessed. Approximately 40 µg each of endotoxin free mammalian cells expressed 
rAamIGFBP-rP1, rAamIGFBP-rP6L and rAamIGFBP-rP6S were combined, and 
concentrated to 25 µg using Jumbosep centrifugal spin filter devices (Pall Life Sciences, 
Post Washington, NY). The first group of mice received 25 µg of rAamIGFBP-rP1, 
rAamIGFBP-rP6S and rAamIGFBP-rP6L (PI group) cocktail. The second group of mice 
received a 25 µg cocktail AAS27 and AAS41 proteins cocktail (AI group), third group 
  62 
received 25 µg of the AI-rTSP and PI-rTSP cocktail.  
In the second experiment, the effects of individual rTSPs were assessed. Each group 
of mice received 40 µg of individual PI- and AI rTSPs. In the third experiment, less 
protein was used, cocktails of both PI-rTSP and AI-rTSP were made by mixing 10 µg of 
the each of the proteins. The first group of mice received a cocktail of 10 µg of each PI 
rTSPs, the second received combinations of the each of 10 µg of AI- and PI-rTSP 
cocktails, the third group received AI-rTSPs, PI combination with 10ug AAS41, the 
fourth group received 10 µg of rAAS27 or rAAS46, the fifth group received 10 µg of 
combination of AI-rTSPs and 2% carrageenan. In the fourth experiment, group of mice 
received each of 10 µg each of PI-rTSPs. Each treatment was injected in 25 µL volumes 
using 25 guage needles (Beckton Dickinson, Franklin Lakes, NJ) (Table 8). 
For all experiments, algae derived inflammation agonist, carrageenan (2% w/v in 
0.9% saline) was used as positive control and normal saline (0.9% NaCl only) as 
negative control in all experiments.  Inflammation was measured as difference in paw 
thickness at 0 minute and the normal saline injected group. For the first and second 
experiment, the footpad swelling was measured at times 0, 20, 40, 60, 120, 240, 360, 720 
and 1440 minutes post injection. For the third and fourth experiments, paw edema was 
measured at 0, 20, 40, 60, and 120 minutes post injection. After measurements, the mice 
were euthanized (3L/minute, CO2) and snap frozen in liquid nitrogen. The paws were 
collected at the level of calcaneus bone for cytokine, chemokine, and myeloperoxidase 
assays (below).  
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Table 8 Treatment groups for paw edema assay in four experiments 
Experiment 
(h) 
Treatments 
groups 
(n=3) 
Dose injected Diluent 
1- 24 h Carageenan 
(CAR)  
2% Normal Saline 
 Normal saline (S) 0.9% Normal Saline 
 PI-rTSPs 25μg  150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 PI-AI rTSPs 25μg PI-rTSPs + 25μg AI-
rTSPs 
Tris Nacl buffer 
2 – 24 h Carageenan 2% Normal Saline 
 S 0.9% Normal Saline 
 AamIGFBP-rP1 25μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 AamIGFBP-rP6 L 25μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 AamIGFBP-rP6 S 25μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
3 – 2 h Car 2% 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 S 0.9% 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 PI-rTSPs 10μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 PI-AI rTSPs 10μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 P+AAS27 10μg PI-rTSPs + 10μg 
AAS27 
150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 P+AAS41 10μg PI-rTSPs + 10μg 
AAS41 
150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 CA 2% Car + 10μg AI-rTSPs 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 AAS27 10μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 AAS41 10μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
4- 2 h Car 2% 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 S 0.9% 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 AamIGFBP-rP1 10μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 AamIGFBP-rP6 L 10μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
 AamIGFBP-rP6 S 10μg 150mM 50mM Tris Nacl buffer 
(pH 7.4) 
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Quantitative RT-PCR analysis of pro-inflammation co-stimulatory markers, pro- and 
anti-inflammatory cytokines, and chemokines in edematous tissues 
 The paws from above were minced in 1 mL TRIzol solution using soft tissue 
scissors followed by sonication using the tissue dismembranator (Thermo Scientific, 
Wilmington, DE). Total RNA was isolated using TRIzol ® method (Thermo Scientific, 
Wilmington, DE). The organic phase during total RNA isolation contained the rest of the 
tissues and were discarded. Following total RNA isolation, mRNA isolation, cDNA 
synthesis was done as described (Thermo Scientific, Wilmington, DE). Template cDNA 
was synthesized from 25 ng mRNA using the Verso cDNA synthesis kit ®, following 
the manufacturer’s protocol (Thermo Scientific, Wilmington, DE). Routinely, qRT-PCR 
was performed as described in chapter 2. All primer sets (forward and reverse) was 300 
nM in concentration. The mRNA expression were determined by delta delta Ct (Livak 
and Schmittgen 2001) method. The GAPDH was used as internal control and normal 
saline injected group was used as calibrator. The primers used in the study are listed in 
Table 9. 
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Table 9 Quantitative RT-PCR primers for pro/anti inflammatory cytokine, chemokine 
and cell surface marker expression 
Target Primer sequence  
TGFβ For: 5-TGGAGCAACATGTGGAACTC-3 
Rev: 5-TGCCGTACAACTCCAGTGAC-3 
CXCL1 For: 5-GACCATGGCTGGGATTCACC-3 
Rev: 5-CCAAGGGAGCTTCAGGGTCA-3 
CCL2 For: 5-CCGGCTGGAGCATCCACGTGT-3 
Rev: 5-TGGGGTCAGCACAGACCTCTCTCT-3 
CCL5 For: 5-ATATGGCTCGGACACCACTC-3 
Rev: 5-TCCTTCGAGTGACAAACACG-3 
CCL11 For: 5-CCAGGCTCCATCCCAACTT-3 
Rev: 5-TGGTGATTCTTTTGTAGCTCTTCAGT-
3 
TNF- For: 5-ATGAGCACAGAAAGCATGA-3 
Rev: 5-GAATGAGAAGAGGCTGAGA-3 
IL-6 For: 5-CTCTGGGAAATCGTGGAAAT-3 
Rev: 5-CCAGTTTGGTAGCATCCATC-3 
IL-1 For:5-CAACCAACAAGTGATATTCTCCATG-3  
Rev: 5-GATCCACACTCTCCAGCTGCA-3 
IL-12 For: 5-GGGAAGACAATAACTGCACC-3  
Rev: 5-GCTGGTCCTTTGTTTGAAAGA-3 
IL-10 For: 5-ATGGTGAAGACGGCCAGA-3 
Rev: 5-CAGGTCTTCAATGTGCTGGTT-3 
CD40 For: 5-GCTATGGGGCTGCTTGTTGA-3 
Rev: 5-ATGGGTGGCATTGGGTCTTC-3 
CD80 For: 5-CTGGGAAAAACCCCCAGAAG-3 
Rev: 5-TGACAACGATGACGACGACTG-3 
CD86 For: 5-CATGGGCTTGGCAATCCTTA-3 
Rev: 5-AAATGGGCACGGCAGATATG-3 
GAPDH For: 5ATGTCGTGGAGTCTACTGGT3 
Rev: 5-GAGTTGTCATATTTCTCGT-3 
 
 
 
 
Myeloperoxidase assay 
 Leukocyte migration into edematous tissue was done by myeloperoxidase assay 
using the myeloperoxidase (MPO) colorimetric assay kit. (Sigma-Aldrich, St. Louis, 
MO). Myeloperoxidase (MPO) is a heme containing enzyme that catalyzes the hydrogen 
peroxidase mediated oxidation of halide ions to hypohalous acid (Agner 1941; Harrison 
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and Schultz 1976). It is a lysosomal protein and is highly expressed in neutrophils and is 
used to detect the level of neutrophils in the tissue (Clark et al., 1987). The half hind paw 
was cut into small pieces and homogenized in the 100 μL MPO buffer as per 
recommended by manufacturer’s protocol and centrifuged at high speed. Aliquots of 
each supernatant were transferred to 96 well plate and MPO substrate and TNB (5-thio-2 
nitro benzoic acid) was added. MPO catalyzes the formation of hypochlorous acid, 
which reacts with taurine to form taurine chloramine, which reacts with chromophore 
TNB, resulting in the formation of colorless product DTMB. The absorbance of color 
change was detected at 412 nm.  In parallel, dilutions of TNB standards were used for 
myeloperoxidase standard curve (OD as a function of units of enzyme activity). The 
MPO activity was measured using the formula: MPO Activity = B x Sample Dilution 
Factor/(Reaction Time) x V, B = Amount (nmole) of TNB consumed, Reaction Time = 
(in minutes, at point stop mix was added), V = sample volume (mL) added to well. 
Statistical Analysis 
              One-way ANOVA followed by Dunnett’s post hoc test was used to determine 
the statistical differences between the controls and treatments using the Prism 6 and 7 
software (GraphPad Software, La Jolla, CA, USA) (Chmelar et al., 2011, Chimedza et 
al., 2017, Sakat et al., 2013, Oz et al., 2017). The statistical significance of mRNA 
transcript abundance was determined for each replicate using the formula 2-ΔΔCT as 
described by Livak and Schmittgen, 2001.  
 
 
  67 
Results 
Cell culture validated pro-inflammation and anti-inflammation rTSPs are functional in 
vivo  
Four experiments summarized in Figs.9A-9D show that the mouse hind paw 
edema assay was successfully used to demonstrate that cell culture validated pro-
inflammatory (PI, rAamIGFBP-rP1, rAamIGFBP-rP6L, and rAamIGFBP-rP6S) and anti-
inflammatory (AI; rAAS27 and rAAS41) rTSPs were functional in vivo. As indicated in 
Fig.9, mice were injected with a high dose of the cocktail or individual PI-rTSPs in the 
first and second experiments (Figs.9A and 9B), while in the third and fourth 
experiments, mice were injected with the low rTSP dose. In all experiments, the algae 
derived inflammation agonist, carrageenan (2%) was used for positive control, and 
normal saline (9 g/L NaCl) for negative control. As shown in Fig.1A injecting mice hind 
paws (n=4) with 25 g of the high dose cocktail of the three PI-rTSPs (cocktail made by 
combining ~40 g of each the three PI-rTSPs) induced edema as determined by paw 
swelling measured using Plythesmometer.  The high dose PI-rTSP cocktail mix 
significantly induced progressive edema through 24 h that was comparable to that 
induced by 2% carrageenan (Fig.9A). Four peak edema points were observed at 20 min 
(0.0415 mL ± 0.003), which was equivalent to the carrageenan (2% in normal saline) 
positive control, at 240 min (0.030 ± 0.008 mL) and 480 min (0.025 ± 0.003 mL) and at 
1440 min (0.02 ± 0.003 mL). When co-injected with the AI-rTSP cocktail, PI-rTSP 
induced edema was reduced by 32, 75, 66, and 100% at 120, 240, 480, and 1440 mins 
respectively (Fig. 9A). In the second experiment (Fig. 9B), mice (n=3) were injected 
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with high dose, 25 g of the individual PI-rTSPs. As demonstrated in Fig.1B, all three 
PI-rTSPs were functional pro-inflammation proteins as they induced edema. As shown 
in Fig.9B, rAamIGFBP-rP6L induced edema that peaked at 480 min (0.013 ± 0.008 mL) 
and 1440 min (0.008 ± 0.003 mL), while rAamIGFBP-rP6S induced edema peaked at 20 
min (0.015 ± 0.005 mL), 40 min (0.015 ± 0.005 mL), 240 min (0.008 ± 0.003 mL), and 
1440 min (0.010 ± 0.005 mL). In the third (Fig.9C) and fourth (Fig.9D) experiments, 
mice were injected with the low dose 10 g of the cocktail (made by combining 10 g of 
each of the PI-rTSPs) or 10 g individual PI-rTSPs. For the third and fourth experiments 
edema was monitored for 120 min (Fig. 9C and 9D). As shown in Fig.9C, peak swelling 
in mice feet that were injected with the low dose cocktail was observed at 20 min (0.033 
± 0.000 mL) and 60 min (0.042 ± 0.002 mL). The administration of AI and PI cocktail 
inhibited edema formation by 90, 72,76 and 66% at 20, 40, 60 and 120 min (Fig. 9C). 
Fig.1D demonstrates that injecting mice with low dosages of individual PI-rTSP induced 
edema. As shown in Fig.9D, paw swelling (0.009 ± 0.003 mL) was apparently above 
negative control at the 120 min time point in mice that were injected with rAamIGFP-
rP1. For rAamIGFBP-rP6S and rAamIGFBP-rP6L, paw swellings of  0  to (0.009 ± 
0.009 mL) , and (0.007 ± 0.003 mL) to (0.037 ± 0.010 mL) were observed from 20 to a 
120 min respectively (Fig. 9D) confirming that even at the low dose, these two proteins 
were pro-inflammatory.  
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Figure 9. Cell culture characterized pro-inflammation (PI) and anti-
inflammation (AI)-recombinant tick saliva proteins (TSPs) are functional in 
vivo. Cocktail or individual pro-inflammatory (PI), rAamIGFBP-rP1, rAamIGFBP-
rP6L, and rAamIGFBP-rP6S or anti-inflammatory (AI), rAAS27 and rAAS41 
rTSPs were injected into mice hind paws as described in materials and methods. 
Mice in Figs.9A and 9B received the high dose of cocktail and individual protein 
respectively, while mice in Figs.9C and 9D received the low dose. Paw thickness as 
an index for the level of inflammation was done at 20, 40, 60, 120, 240, 480, 720 
and 1440 min (Figs. 9A, and 9B), and at 20, 40, 60 and 120 min (Fig. 9C and D). 
Carrageenan and sodium chloride were used for positive and negative control. 
Normal saline values were subtracted from all values plotted in Fig.1. Data is 
represented as mean of three biological replicates ± SEM. Filled squares, red () = 
carrageenan injected, filled circles, blue () = normal saline, filled hexagon, green 
() = high dose PI-rTSP cocktail, purple () = high dose PI-rTSP cocktail co-
injected with high dose AI-rTSP cocktail, Filled triangle () = rAamIGBP-rP1, 
Upside down , purple) = rAamIGBP-rP6L, filled diamond, orange () =  
rAamIGBP-rP6S (B and D), PI-rTSP cocktail and rAAS27 (C) , filled circles, black 
() = PI-rTSP cocktail and rAAS41. rAamIGFBP-rP = A. americanum insulin-like 
growth factor binding protein-related protein, rAAS27 and rAAS41 = A. 
americanum tick saliva serpin 27 and 41. (*) represents p-value <0.05 indicating 
statistically significant difference between normal saline injected group and 
treatments groups using ANOVA Dunnett’s multiple comparisons test. (* i) 
represents p-value <0.05 indicating statistically significant difference between PI-
rTSPs injected group and PI-AI rTSPs injected group using ANOVA Dunnett’s 
multiple comparisons test. No asterisks means non-significance. 
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PI-rTSP induced edema is accompanied by high expression of pro-inflammation, co-
stimulatory markers, cytokines, and chemokines 
One half of the paws in experiments summarized in Figs. 9A-9D were subjected 
to quantitative RT-PCR expression analysis of pro-inflammation co-stimulatory markers 
(Fig.10), pro- and anti-inflammation cytokines (Fig.11), and chemokines (Fig.12). As 
shown in Fig. 10A the CD40 expression was significantly high in 2 h harvested paws 
that were injected with low dose rAamIGFBP-rP1 and rAamIGFBP-rP6S, but not 
rAamIGFBP-rP6S. In contrast CD40 expression was low in 24 h paws that were injected 
with high dose individual PI-rTSPs, except for rAamIGFBP-rP1 (Fig. 10C). Unlike in 2 
h harvested paws in which both rAamIGFBP-rP1 and rAamIGFBP-rP6S induced CD40 
expression significantly above background (Fig. 10A), expression was significantly 
lower in 24 h harvested paws that were injected with high dose individual PI-rTSPs (Fig. 
10B),  except for those that were co-injected with PI-rTSPs, rAAS27 and rAAS41 and 
low dose PI.  
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Interestingly, CD40 was induced significantly above background in 24 h paws 
that were injected the high dose PI-rTSP cocktail, but not those that were co-injected 
with the AI- and PI-rTSP cocktail (Fig. 10D).  For CD80, transcription was significantly 
above background in 2 h harvested paws that were injected with low dose rAamIGFBP-
rP1 and rAamIGFBP-rP6S, but not in 2 h harvested paws that were injected with low 
dose cocktail PI-rTSP (Fig. 10E and 10F). In 24 h paws, CD80 transcription was 
significantly induced in 24 h harvested paws that were injected with the rAamIGFBP-rP1 
high dose as well as the high dose PI-rTSP cocktail (Fig. 10G and 10H). For CD86, 
transcription was induced significantly above background in 2 h harvested paws injected 
with the three individual PI-rTSPs, but those injected with the low dose PI-rTSP cocktail 
(Fig. 10I and 10J). Likewise, significant expression of CD86 transcript was observed in 
24 h harvested paws that were injected with the high dose of rAamIGFBP-rP1 or PI-
rTSP (Fig. 10K and 10L). As shown in Figs. 10D, 10H and 10L, co-injecting the high 
dose PI-rTSP with the AI-rTSP cocktail significantly suppressed transcription of CD40, 
CD80 and CD86.  
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Figure 10. Pro-inflammation rTSP (individual or cocktail) induced edema associated 
with high expression of pro-inflammation co-stimulatory markers. Total RNA that 
extracted from hind paws that were injected with low dose (2 h paws) and high dose (24 h 
paws) PI-rTSP and AI-rTSP was subjected to qRT-PCR analysis to determine the 
expression of pro-inflammatory co-stimulatory markers, CD40, CD80 and CD86. 
Utilizing glyceraldehyde-3-phosphate (GAPDH) gene as the normalizer, relative transcript 
abundance was determined using comparative Ct (ΔΔ Ct) method as described. Relative 
fold change was calculated in comparison with normal saline values. Data is reported as 
mean of three biological replicates ± standard error of mean (SEM) CAR = Carageenan 
(positive control), S = Normal saline, rAamIGFBP-rP = A. americanum insulin-like 
growth factor binding protein-related protein, A127, and AI41 = A. americanum tick 
saliva serpin 27 and 41. PI = pro-inflammation rTSP cocktail, AI = anti-inflammation 
rTSP, PI-AI = PI and AI rTSP cocktail mix, PA127 = PI rTSPs and rAAS27 cocktail, 
PAI141 = PI rTSPs and rAAS41 cocktail mix, % = percentage sign shows the percent 
suppression. (*) represents p-value <0.05 indicating statistically significant difference 
normal saline injected group and treatments groups using one way ANOVA. No asterisks 
means non-significance. 
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Figs.11 and 12 demonstrate that PI-rTSP induced edema (Fig. 9) was 
accompanied by differential up regulation of pro-inflammatory cytokines and 
chemokines. As shown in Fig.11, the TNF-α transcript was significantly up regulated in 
2 h harvested paws that were injected with low dose individual PI-rTSPs (Fig. 11A) and 
the cocktail PI-rTSP (Fig. 11B). As shown in Fig. 11C, the TNF-α transcript was not 
induced above background in 24 h  harvested paws that were injected with the high dose 
of the individual PI-rTSPs, while significant expression was observed in those that were 
injected with the high dose of the PI-rTSP cocktail. Likewise, the IL-1 transcript was 
significantly up regulated in 2 h paws that were injected with the low dose of individual 
(Fig. 11E) or cocktail (Fig. 11F) of PI-rTSPs.  Similarly, the IL-1 transcript was 
significantly induced in 24 h harvested paws that were injected with individual (Fig. 
11G) or cocktail (Fig. 11H) PI-rTSPs, albeit at low levels when compared to 2 h 
harvested paws (Figs. 11E and Fig. 11F). In the case of IL-6, significant expression 
above negative control was observed in 2 h paws that were injected with individual PI-
rTSPs, but not in 2 h harvested paws that were injected with the low dose cocktail (Fig. 
11J). It is interesting to note that the profile of TGFβ (Fig. 11M-P), an anti-inflammation 
cytokine, although in low amounts, was comparable to pro-inflammation cytokines: 
TNFα and IL-1 in 2 h harvested paws that were injected with low dose individual 
proteins (Fig. 11M). It is also notable that co-injecting PI and AI-rTSP in 24 h harvested 
paws (Fig. 11P) did not affect TGFβ transcription  
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Figure 11. Pro-inflammation cytokines are significantly expressed in cocktail or 
individual pro-inflammation (PI)-rTSP induced edema. Total RNA that extracted from 
hind paws that were injected with low dose (2 h paws) and high dose (24 h paws) PI-rTSP 
and AI-rTSP was subjected to qRT-PCR analysis of pro-inflammatory cytokine, TNFα, 
IL1, IL6 and anti-inflammatory cytokine TGFβ. Normalized against glyceraldehyde -3-
phosphate (GAPDH) for internal control, relative abundance of transcripts was determined 
using comparative Ct (ΔΔ Ct) method as described. Data is reported as Mean (M) of three 
biological replicates ± SEM. CAR = Carageenan (positive control), S = Normal saline, 
rAamIGFBP-rP = A. americanum insulin-like growth factor binding protein-related 
protein, A127, and AI41 = A. americanum tick saliva serpin 27 and 41. PI = pro-
inflammation rTSP cocktail, AI = anti-inflammation rTSP, PI-AI = PI and AI rTSP 
cocktail mix, PA127 = PI rTSPs and rAAS27 cocktail, PAI141 = PI rTSPs and rAAS41 
cocktail mix, % = percentage sign shows the percent suppression. (*) represents p-value 
<0.05 indicating statistically significant difference between normal saline injected group 
and treatments groups using one way ANOVA. No asterisks means non-significance.  
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The effects of co-injecting PI- and AI-rTSPs on cytokine expression were mixed. 
In Fig.11B, TNF-α transcript abundance was respectively reduced by 36.09  and 35.50 
% in low dose PI-rTSP cocktail 2 h harvested paws that were co-injected with the AI-
rTSP cocktail and rAAS27. Similarly, co-injecting the AI-rTSP with the high dose PI-
rTSP cocktail suppressed TNF-α transcript levels by 74.11 at 24 h% (Fig.11D). For IL-1, 
co-injecting AI-rTSPs, individually or as a cocktail had no effect, and appeared to 
slightly enhance IL-1 transcription in 2 and 24 h paws (Fig. 11F, H). Likewise, for IL-6, 
co-injecting AI-rTSP with PI-rTSPs suppress transcription level by 62.72% (Fig. 11J). 
However, co-injecting with rAAS27 in low dose PI-rTSP cocktail 2 h harvested paws 
(Fig. 11J) or with AI-rTSP cocktail in 24 h high dose PI-rTSP harvested paws (Fig. 11L) 
enhanced transcription.  
We also assessed the effect of AI-rTSPs on carrageenan injected animals. Co-
injection of AI-rTSPs with carrageenan did not change the transcripts of TNFα, IL-1 and 
TGFβ, However, the IL-6 was lowered to 38.67% respectively (Fig. 11J) 
Fig. 12 summarizes the involvement of chemokines PI-rTSP induced 
inflammation. It was interesting to note that all chemokines investigated here were 
highly transcribed in 2 h paws that were injected with individual PI-rTSPs or the cocktail 
(Fig. 12A, 12B, 12E, 12F, 12I, 12J, 12M, 12Q and 12R) with the exception of CCL5 for 
which transcription could not be confirmed in 2 h paws that were injected with the low 
dose PI-rTSP cocktail.    
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It is notable that in both cocktail or individual PI-rTSP injected animals, the four 
chemokines, CXCL1, CCL2, CCL3 and CCL11 were expressed at much higher levels at 
2 h than at 24 h (Fig. 12A, 12B, 12E, 12F, 12I, 12J, 12M, 12P, and 12Q). Whereas co-
injecting cocktail or individual AI-rTSPs did not suppress cytokine expression of IL-1 
(Fig.11 E, L), CXCL1, CCL2, CCL3 and CCL11 transcripts were significantly 
suppressed by up to 97.54, 99.51, 91.98. 95.43 % in 2 h harvested paws that were co-
injected with cocktail or individual AI-rTSPs (Fig. 12B, 12F, 12J and 12R). Likewise, 
chemokine transcripts CXCL1, CCL2, CCL3 and CCL11 were also suppressed to 52.84, 
47.52, 64.50 and 72.35 %in 24 h harvested paws.   
In contrast expression of the CXCL5 chemokine was enhanced in animals that 
were co-injected with AI-rTSPs (Fig. 12P). While the effect of AI-rTSPs co-injected 
with PI-rTSPs was much higher, AI-rTSPs lowered CXCL1 expression in carrageenan 
induced inflammation (Fig. 12B) 
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Figure 12. Chemokine transcripts are highly expressed at 2 h and 24 h in pro-
inflammation rTSP induced edema. Total RNA that extracted from hind paws that were 
injected with low dose (2 h paws) and high dose (24 h paws) PI-rTSP and AI-rTSP was 
subjected to qRT-PCR expression analysis of chemokines, CXCL1, CCL2, CCL3, CCL5 
and CCL11. Normalized against glyceraldehyde -3-phosphate (GAPDH) for internal 
control, relative abundance of transcripts was determined using comparative Ct (ΔΔ Ct) 
method as described. Data is reported as Mean of three biological replicates (M± SEM) 
CAR = Carageenan (positive control), S = Normal saline, rAamIGFBP-rP = A. 
americanum insulin-like growth factor binding protein-related protein, A127, and AI41 = 
A. americanum tick saliva serpin 27 and 41. PI = pro-inflammation rTSP cocktail, AI = 
anti-inflammation rTSP, PI-AI = PI and AI rTSP cocktail mix, PA127 = PI rTSPs and 
rAAS27 cocktail, PAI141 = PI rTSPs and rAAS41 cocktail mix, % = percentage sign 
shows the percent suppression. (*) represents p-value <0.05 indicating statistically 
significant difference between normal saline injected group and treatments groups using 
one way ANOVA. No asterisks means non significance. 
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Discussion 
The long-term research in the lab is to understand functions of tick saliva 
proteins at the tick feeding site. Thus, an important goal of this third chapter was to 
validate if in vitro validated pro-inflammation (PI) and anti-inflammation (AI) rTSPs 
were functional in vivo. Data presented demonstrated that at least three of five PI-rTSPs 
and the two AI-rTSPs that were identified in the second chapter were functional in vivo.   
It was interesting to note that similar to an algae derived inflammation agonist, 
carrageenan, the injection of rAamIGFBP-rP1, AamIGFBP-rP6S, and AamIGFBP-rP6L 
individually or as a cocktail induced edema in mice hind paws, which was suppressed 
when mice were co-injected with the rAAS27 and rAAS41 cocktail. Our lab has recently 
demonstrated that rAAS27 (Tirloni et al., in preparation) and rAAS41 (Kim et al., in 
preparation) suppressed formalin and compound 48/80 induced edema in rats. These 
studies suggested rAAS27 and rAAS41 may block inflammation by respectively 
inhibiting pro-inflammation proteases, trypsin  and chymase induced by these 
compounds, which is abundant in the skin. Whether or not these two proteases were 
associated with PI-rTSP induced edema was not investigated, however it would be 
interesting to confirm in future work. 
Several studies have demonstrated that the most potent costimulatory signaling 
pathways in immunity and inflammation include CD28/B7 (CD80 and CD86) and 
CD40/CD40L (CD154) systems (Somaza and Lanier 1995; Brodskyn et al., 2001; 
Slawek et al., 2013). Expression of co-stimulatory molecules on the macrophages and 
other APCs is crucial for determining the nature and extent of the immune response 
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(Guermonprez et al., 2002; Santin et al., 1999). Furthermore, they play a major role in 
activation of T cells leading to proliferation, cytokine production and development of 
effector function (Somaza and Lanier 1995).  We investigated the expression of co-
stimulatory markers on macrophages by conducting systematic examination of 
costimulatory marker expression relating to cytokine and chemokine expression. Our 
results show that CD40, CD80 and CD86 was induced by individual PI-rTSPs at 2 h, 
albeit at low levels, at 24 h. This analysis shows that the expression of all three markers 
are in parallel, which shows that these markers express concurrently at the surface of 
antigen presenting cells. While the costimulatory markers are also expressed by various 
APCs (Kern et al., 2001; Zhan et al., 2003; Hellman et al., 2007), we limited our 
investigation to macrophage specific responses relating to effects observed in vitro. 
Next, we were interested in looking at cytokine and chemokine responses 
following activation confirmed by cell surface marker expression. Our analysis showed 
that rTSPs induced high levels of TNF-α, IL-1, IL-6  at 2 h and low levels at 24 h. 
CD40, CD80, CD86 signal via NfKb to induce numerous cytokines like TNF-α, IL-1, 
IL-6 (Medzhitov 2001). Moreover, macrophages, when activated secrete prodigious 
amounts of pro-inflammatory chemokines to attract immune cells for pro-inflammatory 
activity (Fujiwara and Kobayashi 2005). We investigated the expression of few 
chemokine CXCL1, CCL2, CCL3, CCL5 and CCL11.  CXCL1 is expressed by 
macrophages, neutrophils and epithelial cells and have neutrophil chemoattractant 
properties (Iida et al., 1990). CCL2 or monocyte chemoattractant protein 1 recruits 
monocytes, memory T cells and dendritic cells (Carr et al., 1994). CCL3, called 
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macrophage inflammatory protein 1-alpha is involved in recruitment and activation of 
poly-morphonuclear leukocytes (Wolpe et al., 1988). CCL5 is classified as chemotactic 
cytokine or chemokine for T cells, eosinophils and basophils (Donlon et al., 1990) and 
CCL11 or eotaxin is responsible for migration of eosinophil at the inflamed site (Kitaura 
et al., 1996). Chemokine expression acts within minutes, few hours and last up to 24 h 
(Ahn et al., 2007; Eberlein et al., 2010). Therefore, we observed the highest chemokine 
CXCL1 and CCL2 transcript at 2 h. The expression of chemokines CCL3, CCL5 and 
CCL11 was induced by individual and combination PI-rTSPs but sustained till 24 h. 
Therefore, our data confirmed the edema formation as a result of various cellular 
migration at the immune site. Although we did a systematic examination of different 
chemokines responsible for different cell migration, it would be of interest to examine 
the role of specific cell type at the injection site.  
In addition to inflammatory activities, macrophages have the potential to 
contribute to remission of inflammatory episodes by inhibiting costimulatory markers 
and pro-inflammatory responses (Fujiwara and Kobayashi 2005). Either external signal 
by pathogens for longer survival (Weng et al., 2007) or the inhibitory mechanisms of the 
immune system shut the inflammatory signals from cells at inflamed site (Fujiwara and 
Kobayashi 2005). TGFβ produced by many cell types, in synergy with IL-10 play a 
crucial role in resolution of the response (Gong et al., 2012). Our results shows that 
TGFβ is induced at low levels for induction of anti-inflammatory effect. Both individual 
and combination PI-rTSPs induced TGFβ expression at low levels. Since TGFβ is a late 
phase expressing cytokine (Sadeghi et al., 2011), the effect was more at 24 h than 2 h, 
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indicating the effect of rTSP specific response and suppression of pro-inflammatory 
cytokine transcription at 24 h. On the other hand, AI-rTSPs also induce TGFβ but not 
more than PI-rTSPs. Interestingly, AI rTSPs had suppressive effect on TNF-α, IL-1, 
CXCL1, CCL2, CCL3 and CCL11 when co-injected with PI-rTSPs, showing an 
inhibitory response. Percent suppression was higher at 2 h compared to 24 h because of 
the highest pro-inflammatory response at 2 h. It was interesting to note that CCL5 
expression was higher at groups injected with AI-PI rTSP at 24 h indicating possible 
synergistic effect. This could be possible for migration of T cells (Murooka et al., 2008). 
Therefore, the AI-rTSPs suppress the pro-inflammatory activities induced by PI rTSPs 
and the anti-inflammatory effect of AI-rTSPs may have been through different pathway 
than TGFβ signaling and remains to be investigated.  
We were also interested in understanding the effects of AI-rTSPs on carrageenan 
induced edema. While there was no suppressive effect on co-stimulatory molecules, 
cytokines TNF-α, IL-1, TGFβ, chemokine CCL2, CCL3, CCL5 and CCL1, suppressive 
effects on IL-6, CXCL1 was observed indicating possible inference of AI-rTSPs on the 
carrageenan induced pathway. The effect of carrageenan inflammation is also shown to 
be suppressed by various molecules (Amdekar et al., 2012; Ahmad et al., 2016). 
Therefore, one possible effect is AI rTSPs affect carrageenan induced pathway by 
downregulating certain cytokines. 
Previous studies demonstrated the influence of tick bites, tick saliva and its 
components on the innate and adaptive immune response (Hajnicka et al., 2005; 
Leboulle et al., 2002; Liu et al., 2014). However, these studies used in vitro and in vivo 
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assay using tick saliva or salivary gland extracts and may therefore not reflect the events 
induced by saliva molecules that might be very important in tick feeding. Only few 
studies of immune reaction to tick bites have been performed in mouse skin in vivo. For 
example, molecular investigations of early innate immune response in mice were found 
by upregulation of chemoattractants for monocytes, neutrophils and dendritic cells 
CXCL1, CXCL5, CCL2 and CXCL4 (Heinze et al., 2012). Consistent with these results, 
in BALB/c mice, 6-12 h post infestation, tick bite lesions are characterized histologically 
by strong innate reaction with predominance of neutrophils and mononuclear cells 
(Mbow et al., 1994). Similarly, an 84 kD Haemaphysalis longicornis protein induces an 
immediate hypersensitivity reaction as a type of inflammatory response (Mulenga et al., 
2000). Also saliva of Rhiphicephalus sanguineus was shown to induce basophil and 
neutrophil infiltration (Szabo et al., 1995). These early alterations in tick bite lesions are 
comparable to our findings in paw edema showing an initial strong, transient innate 
immune response.  
Studies have shown that tick saliva induces Th2 specific response throughout the 
feeding, showing higher IL-4, IL-5, IL-10 expression (Leboulle et al., 2002; 
Langhansova et al., 2015; Mejri and Brossard 2007). These responses increase as 
feeding continues (Langhansova et al., 2015). This facilitates transmission of pathogens 
such as Rickettsia spp., Ehrlichia spp., and Borrelia burgdorferi (Saraiva et al., 2014; 
Starkey et al., 2015; Labuda and Nuttall 2004). Also, the initial pro-inflammatory 
cytokines for these pathogens are beneficial for their proliferation and survival (Meddeb 
et al., 2016; Sahni et al., 2009; Lepidi et al., 2009). In our study, we suspect that the PI-
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rTSPs induce the pro-inflammatory effect during the initial tick feeding process, hence 
possibly aiding in pathogen transmission. However, we were not able to show the 
predominant Th2 response by AI-rTSPs even though they suppress the PI-rTSPs induced 
pro-inflammatory response effect. This may be due to several reasons, first, being the 
development of Th2 response require longer than 48 h response, and second, the mRNA 
levels of cytokines that promote T cells migration may not be sensitive to actual 
cytokine detection. Thus, our idea was to detect the PI-rTSPs affecting the initial phase 
of feeding. This critical window of time for ticks to transmit pathogens and promoting 
modulatory effect on host response underlies the importance of tick removal as early as 
possible and hence control tick feeding.  
 In conclusion, PI rTSPs produce a strong innate immune response with possible 
infiltration of mononuclear cells, neutrophils, dendritic cells and up-regulation of 
chemokines and cytokines and could be recognized as biomarkers of acute phase of tick 
feeding. We suspect that tick saliva could weaken these responses and modulate the host 
towards Th2 responses. This could facilitate blood intake and transmission of pathogens. 
Thus, this study contributes to a deeper understanding of tick feeding physiology and 
identification of TSPs that are involved in mediating A. americanum tick’s evasion of 
host defenses. 
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CHAPTER IV 
EVALUATE PROTECTIVE EFFICACY OF PRO-INFLAMMATORY RTSPS 
AGAINST TICK FEEDING 
Introduction 
Work in our lab has described six Amblyomma americanum tick saliva insulin-
like growth factor binding proteins-related proteins (AamIGFBP-rP) (Mulenga et al., 
2007, 2010, Kim et al, in preparation). Transcripts for three of these proteins 
AamIGFBP-rP1, AamIGFBP-rP6S, and AamIGFBP-rP6L were originally identified 
among genes that were significantly up regulated in A. americanum ticks that were 
stimulated to start feeding on cattle (Mulenga et al., 2007). In subsequent studies 
AamIGFBP-rP1, AamIGFBP-rP6S, and AamIGFBP-rP6L were demonstrated to be 
important in tick feeding physiology and general tick fitness as disruption of encoding 
transcripts using RNAi silencing resulted in reduced blood meal sizes, darkening and 
softness of the cuticle (Mulenga et al., 2013). In the same study, transcriptional analysis 
suggested these molecules were expressed in multiple tick organs (Mulenga et al., 2010), 
and in recent studies, were demonstrated present in the tick saliva proteome (Radulovic 
et al., 2015; Kim et al., in preparation). Although structurally, they are predicted to bind 
insulin-like growth factors, we showed that all three proteins, AamIGFBP-rP1, 
AamIGFBP-rP6S, and AamIGFBP-rP6L, bound human insulin (Radulovic et al., 2015; 
Radulovic et al., in preparation). Results from chapters 2, 3 and 4 of this dissertation 
have provided further insight into the functional roles of these proteins as pro-
inflammatory tick saliva proteins that enhanced macrophage phagocytosis.  Collectively 
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these data from previous studies cited here (Mulenga et al., 2007; 2013; Radulovic et al., 
2015 and unpublished Kim et al., in preparation) and data in this dissertation 
demonstrate that AamIGFBP-rP1, AamIGFBP-rP6S, and AamIGFBP-rP6L are 
functionally important to tick feeding physiology. Thus there is likelihood that blocking 
functions of the three proteins could affect tick-feeding success. The goal of this fifth 
chapter was to determine immunogenicity and anti-tick vaccine efficacy of human 
embryo kidney (HEK) cell expressed rAamIGFBP-rP1, rAamIGFBP-rP6S, and 
rAamIGFBP-rP6L against tick feeding in rabbits. The objective was to investigate if 
immunization with the cocktail of mammalian cell expressed rAamIGFBPrP-1, 
rAamIGFBP-rP6S rAamIGFBP-rP6L (PI-rTSPs) was protective against A. americanum 
feeding success.  
Commercialization of two vaccines against Rhiphicephalus microplus based on 
midgut antigens, Bm86 and Bm95 (Rodriguez et al., 1995; Willadsen et al., 1995; De la 
Feunte et al., 2000) gave credence to the concept of anti-tick immunization as a 
sustainable alternative tick control. The limitations of this vaccine such as effectiveness 
against a single tick specie and being limited to specific regions were quickly realized.  
The search for effective anti-tick vaccine antigens has continued such as an immune-
dominant p29 Haemaphysalis longicornis that caused 50% mortality of larvae and 
nymphs (Mulenga et al., 1999), AAS19 which reduced adult A. americanum feeding 
efficiency by 50% (Kim et al., 2016), and a cement protein, 64P, that conferred 
protective immunity against R. appendiculatus as revealed by up to 48% and 70% 
mortality of nymph and adult ticks (Havlikova et al., 2009). In other studies a conserved 
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antigen, Subolesin, that are important in Ixodes scapularis innate immunity (Almazán et 
al., 2003), conferred protective immunity against I. scapularis, A. americanum, R. 
microplus, R. annulatus and Dermacentor variabilis (Almazán et al., 2005; 2010; 
Canales et al., 2009; De la Fuente et al., 2010) Another molecule called Ferritin 2, an 
iron storage protein, has been shown to reduce feeding, oviposition and fertility in I. 
ricinus, R. microplus and R. annulatus (Hajdusek et al., 2010). Although few in number, 
anti-tick vaccination studies against A. americanum are ongoing. In 2010, De la Fuente 
et al. immunized cattle against recombinant antigens encoding for threonyl-tRNA 
synthetase (2C9), 60S ribosomal proteins L13a and L13e and observed >30% protection 
against adults and nymphs, demonstrating feasibility of developing vaccines for control 
of lone star tick infestation (De la Fuente et al., 2010). Our lab recently demonstrated 
that rabbit immunity to a tick serpin AAS19, caused 60% of ticks fail to lay eggs and 
50% reduction in engorgement weights (Kim et al., 2016). The observations that 
immunization of animals with single antigens confers partial protection have resulted in 
renewed focus to develop a vaccine that targets multiple tick antigens. In this fifth 
chapter of the dissertation, an attempt was made to evaluate the anti-tick vaccine 
efficacy of A. americanum pro-inflammation peptides that have been described in earlier 
chapters of this dissertation.  
Materials and Methods 
Expression of pro-inflammation (PI) recombinant (r) AamIGFBP-rP1, AamIGFBP-rP6 
long, AamIGFBP-rP6 short in mammalian cells 
Expression of PI-rTSPs (AamIGFBP-rP1, AamIGFBP-rP6L, AamIGFBP-rP6S) 
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were done in human embryonic kidney cells as described in chapter II. HEK-293F 
suspension cultures were grown to 1 × 10
6 
viable cells/ml in 293 Freestyle medium 
(Thermo Scientific, Wilmington, DE) with shaking at 125 rpm in an incubator set to 8% 
CO2 and 85% relative humidity. For transfection in suspension cultures, 100 μg 
recombinant plasmids and 100 μL of the transfection reagent, 293fectin (Thermo 
Scientific, Wilmington, DE) were incubated with ~1-2 mL Opti-MEM medium (Thermo 
Scientific, Wilmington, DE) separately. Following incubation, 293fectin and 
recombinant plasmids were combined and incubated for an additional 30 min and then 
added to a cell culture containing 1 x 108 HEK-293F cells. The cell suspension was 
harvested after 72 h and cell viability was routinely confirmed by trypan blue staining 
(<90% viability).  
 After verification of rTSP expression using western blotting analyses, cell lysates 
and the supernatant were incubated with the beads conjugated with the antibody to the 
FLAG tag (Sigma- Aldrich, St. Louis, MO) overnight at 4°C. The bound rTSPs were 
eluted using 0.1M Glycine buffer (pH 3.5) and neutralized with 1M Tris-HCl (pH 8). 
Following verification of protein elution, fractions were combined and dialyzed against 
Tris- HCl buffer (50 mM Tris, 150mM NaCl, pH 7.4) using spin filters (Pall Life 
Sciences ®, Port Washington, NY). Protein quantification was done using bicinchoninic 
acid assay (BCA assay) according to instructions provided by the manufacturer (Thermo 
Scientific, Wilmington, DE). 
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SDS-PAGE and western blotting analyses 
 Routine SDS-PAGE with Coommassie blue or silver staining and western 
blotting analyses was done to confirm purification. Proteins were resolved in 12.5% 
acrylamide/bis-acrylamide gels and stained with silver and coomassie stains. For western 
blotting analyses, resolved proteins were transferred to a PVDF (Polyvinylidene 
 
 
 
 
 
 
  
 
 
 
 
E1 E2 E3 E1 E2 E3 E1 E2 E3 
IGFBP-rP6-L IGFBP-rP1 IGFBP-rP6-S 
25 
37 
50 
75 
100 
20 
L (kD) 
Figure 13. Expression and affinity purification of Amblyomma americanum 
IGFBP-rP1, IGFBP-rP6 long and IGFBP-rP short. Affinity purified recombinant 
tick saliva proteins were subjected to SDS-PAGE and western blot using antibody to 
flag tag. Left to right: Ladder (L), kD (kilodaltons), IGFBP-rP1 (tick insulin like growth 
factor binding protein 1), IGFBP-rP6-L (tick insulin like growth factor binding protein 
long), IGFBP-rP6-S (tick insulin like growth factor binding protein short), E (1-3): 
Elution from purifications. 
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difluoride) membrane using the Thermo-fisher western blot transfer system (Thermo 
Scientific, Wilmington, DE). Following transfer, membranes were blocked overnight at 
4C in 5% skim milk in PBS-Tween20. Subsequently membranes were washed and then 
incubated with anti-flag antibody conjugated with HRP (1:5000). The membranes were 
washed using PBS-0.05% Tween20 and proteins were confirmed using 
chemiluminescent substrate on X-ray films or using the Chemidoc MP gel doc (Biorad, 
Hercules, CA). 
Results and Discussion 
Insufficient expression and purification of rAamIGFBP-rP1, rAamIGFBP-rPL, 
AamIGFBP-rP6S for immunizations 
The fifth chapter of this dissertation did proceed as intended. The limitation was 
that, except for rAamIGFBP-rP1, efforts to produce sufficient amounts of rAamIGFBP-
rP6L and rAamIGFBP-rP6S for immunization were unsuccessful (Fig.13). As shown in 
figure 13, the concentrated purifications confirmed expression as verified by western 
blot analyses using anti-body to Flag tag. The protein bands were observed at the 
expected molecular weight, with rTSPs rAamIGFBP-rP1 showing intense bands 
following rAamIGFBP-rP6L and rAamIGFBP-rP6S. Despite positive expression and 
high sensitivity of western blot analyses, amounts of rAamIGFBP-rP6L and 
rAamIGFBP-rP6S were not sufficient to proceed with immunization. 
Several possibilities could explain failures encountered in this fifth chapter. One 
possibility is that the transiently transfected genetic material can be lost by several 
environmental factors and cell divisions. Therefore, the inability of cells to produce 
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enough proteins due to high passage number of the cells may have contributed in loss of 
plasmid during cell division. Another possibility could be the requirement of increasing 
amounts of plasmid DNA for large scale expression. Similar to virus based systems that 
include an additional production step to generate sufficient amount of proteins for virus 
production (Condreay et al., 1999), it also becomes necessary to scale up the plasmid 
concentration for large scale expression in HEK expression system. Even though large 
scale expression was attempted by using increasing concentrations of plasmid, the 
conditions for large scale peptide production must be different compared to small scale 
expression.  
As alternative strategies to obtain higher production concentrations of proteins, 
293A cells were re-transfected and isolated from positive colonies. Fresh stocks of re-
transformed bacteria containing expression plasmid were made and plasmid purification 
was done using ultra-pure water. The 293 freestyle cells (Kindly provided by Dr. 
Mwangi, Kansas State University, Manhattan, Kansas) were transfected with newly 
isolated plasmid. The expression culture was purified with new FLAG tag affinity beads. 
While the expression was consistently positive, I failed to purify enough recombinant 
proteins for immunization experiments. Failure to express high amount of recombinant 
IGFBPs prevented successful completion of the immunization and tick challenge 
experiments as outlined in my proposal. To attempt production of sufficient amounts of 
antigen, alternative strategies were developed. These include: (i) expression in stably 
transfected insect cells were developed, and (ii) expression in adherent 293 cells.  
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CHAPTER V 
CONCLUSIONS 
Summation of findings 
  The innate immune defense is the host’s first defense mechanism that ticks 
encounter (Wikel 2013). Ticks regulate the macrophages for the maintenance of feeding 
lesions (Poole et al., 2013). Under this assumption, this dissertation focused on studying 
the effects of fifteen yeast- and insect cell- produced Amblyomma americanum and 
Ixodes scapularis recombinant tick saliva proteins (rTSP) on macrophage function. In 
chapter 2, preliminary analyses showed that out of fifteen rTSPs, five A. americanum 
rTSPs (here in referred to as pro-inflammation [PI] proteins) including Insulin-like 
growth factor-binding proteins-related proteins, AamIGFBPrP-1, AamIGFBP-rP6S, and 
AamIGFBP-rP6L, Serine protease inhibitor (AAS8), tick carboxypeptidase inhibitor 
(AamTCI) modulate macrophages by inducing expression of pro-inflammation cell 
surface co-stimulatory markers CD40, CD80 and CD86 and secretion of nitric oxide.  
These data were generated using an in vitro culture system using a macrophage cell 
line, RAW 264.7. In vitro results prompted additional recombinant protein production 
to verify the effect using mammalian-expressed proteins rAamIGFBPrP-1, 
rAamIGFBP-rP6S, rAamIGFBP-rP6L, AAS8 and TCI. Interestingly, the response of 
macrophages was comparable to the preliminary analysis. I further confirmed that 
treatment-activated macrophages promoted the expression of pro-inflammatory 
cytokines including TNFα, IL-1, IL-6 and IL-10 induced by rTSPs. In contrast, two A. 
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americanum serine protease inhibitors, AAS27 and AAS41 (AI), reversed the pro-
inflammatory response induced by LPS or PI-rTSPs.  
I was curious to investigate if cell culture validated PI-rTSP and AI-rTSP were 
functional in vivo. Therefore, I investigated the role of PI-rTSPs and AI-rTSPs in vivo 
using a paw edema assay. Interestingly, cell culture results were validated in vivo as PI-
rTSPs induced edema while AI-rTSP surpressed edema. Results showed that PI-rTSPs 
are positive regulators of cytokines TNFα, IL-1, IL-6 and chemokines CXCL1, CCL2, 
CCL3, CCL5 and CCL11 that were directly related to edema progression and 
inflammation. In contrast, AI- rTSPs are negative regulators of pro-inflammation 
markers including chemokines TNFα, CXCL1, CCL2 and CCL3.   
 Another interesting observation was that rAamIGFBPrP-1, rAamIGFBP-rP6S, 
and rAamIGFBP-rP6L treatment of macrophages not only enhanced genes that are 
associated with phagocytosis, but also enhanced phagocytosis in macrophages. In the 
context of tick transmission of tick borne pathogens, the finding is particular 
significant. Several tick-borne pathogens have been shown to exploit tick proteins to 
establish infection in the mammalian host (Nuttall and Labuda 2008, Hovious et al., 
2008; Labuda et al., 1993). Transmission of Amblyomma spp.-vectored tick-borne 
pathogens such as Erhlichia chaffeensis (Varela-Stokes 2007), E. ruminantium (Bekker 
et al., 2002), and the newly described tick-borne viruses, severe fever with 
thrombocytopenia virus (SFTSV) and heartland virus (HRTV) (Yun et al., 2014; 
Matsuno et al., 2017) target macrophages through phagocytosis for survival (Banajee et 
al., 2016, Ganta et al., 2009) and transmission. Could the observed enhancement of 
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phagocytosis suggest functional role(s) for rAamIGFBPrP-1, rAamIGFBP-rP6S, and 
rAamIGFBP-rP6L in vector competence of A. americanum?  
Another application or significance of the research is finding potentially 
attractive candidates for prophylactic applications. The field of medicine have evolved 
to take advantage of inflammatory mediators in treatment of inflammation-related 
diseases and vaccine development. The therapeutic use of nonspecific immune-
modulatory molecules that boost host defenses have been used to treat chronic diseases 
(Yamashita et al., 2015). Based on my dataa, the bidirectional signaling presents new 
potential avenues for the development of therapeutic interventions targeting co-
stimulatory and inflammatory molecules. As a result, deciphering the 
CD40/CD80/CD86 signaling pathway and the molecules that govern their expression is 
essential. In vaccine development, adjuvants made of recombinant proteins or ligands 
of immune cells potentiate the host response to infections. Pharmacological agents with 
anti-inflammatory properties are used to control adverse pathological conditions caused 
by inflammatory mediators (D’Elia et al., 2013). CD80 and CD86 have been identified 
as key regulators of immune activation, tolerance regulation and the skewing of T cell 
responses in disease models, such as graft-vs-host diseases, cancer, and autoimmune 
diseases (Salomon and Bluestone 2001). These therapeutic approaches are used to 
enhance the efficacy of antimicrobials in treatment of many diseases. Therefore, 
exploring the therapeutic potential of tick saliva proteins described here needs further 
investigation.  
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Future perspectives  
 First, although the dissertation achieved the majority of its objectives, there were 
some limitations. First, from the preliminary analysis, the in vitro assays utilized 
immortalized mouse cell lines, Raw macrophages. The advantage was the ease of 
culturing, determining macrophage-specific response and consistency within technical 
replicates. However, the immortalized cell lines may not mimic 100% of the primary 
cell function. However, the observation that cell culture data were validated using an in 
vivo assay provided credence to the cell culture-based findings in this dissertation. 
Second, I was unsuccessful in obtaining sufficient amount of rTSPs for experimental 
animal immunization and tick-feeding trials. One possible reason was the use of a 
transient expression system for obtaining high concentrations of rTSPs. The alternative 
strategy could be the expression of recombinant proteins in yeast or insect cell 
expression systems.  
 Overall, by combining functional and biological characterization, this 
dissertation provides additional insights into elucidating the pro- and anti-inflammatory 
function of three A. americanum IGFBPs and two serine protease inhibitors in tick 
feeding physiology. The observations that some of the recombinant A. americanum 
proteins investigated promoted inflammation and others down-regulated inflammatory 
markers was counter-intuitive, but not entirely novel. As ticks are expected to suppress 
inflammation to successfully feed and transmit pathogens, it is counter-intuitive for 
ticks to secrete proteins such as the 84 kDa in Haemaphysalis longicornis that induced 
immediate hypersensitivity in rabbits (Mulenga et al., 2000) and tick histamine release 
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factor which stimulated basophils to secrete an inflammation agonist, histamine 
(Mulenga et al., 2003). While transcriptional and gene expression analyses showed 
remarkable gene activation by PI-rTSPs and AI-rTSPs, further studies are required to 
understand the differential regulation between protein and transcripts. It would be of 
interest to identify the transcriptional factors involved for each protein in the context of 
pathways or signaling molecules described. Moreover, studies could be conducted to 
investigate the role of cytokines from T cells for interaction/binding of tick saliva 
proteins on these molecules. Some remaining questions to be resolved would be 
determining the TSP interactions with receptors of host macrophages, and detection of 
specific metabolic pathways and their role in pathogen transmission. Additionally, it 
would be of interest to study the adjuvanticity and anti-tick vaccine efficacy of pro-
inflammatory rTSPs against ticks and the transmission of tick-borne diseases. Whether 
or not their inclusion in vaccines can result in protection from tick feeding and/or 
pathogen transmission remains to be investigated.  
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